Pharmacology Flashcards
6-mercaptopurine (6-MP)
6-thioguanine (6-TG)
Azathioprine (prodrug of 6-MP)
purine analogs
inhibit de novo purine synthesis
pathway 1:: activated by hypoxanthineguanine phosphoribosyl transferase (HGPRT) to make active metabolites resulting in purine synthesis inhibition (cytotoxic)
pathway 2: Allopurinol competitively inhibits Xanthine oxidase(XO) and thiopurine methyltransferase (TPMT) in the liver and preventing formation of inactive metabolites. Results in shunting to pathway 1 and increased activation
use: IBD and maintenance of cancer remission, organ rejection, RA, SLE, steroid weaning off
Mycophenolate and ribavirin
inhibits inosine monophosphate dehydrogenase
IMP –x—> GMP
Hydroxyurea
Inhibits ribonucleotide reductase in purine and pyrimidine synthesis in s phase
for myeloproliferative disorders and sickle cell (increased levels of HbF)
Methotrexate (MTX), trimethoprim (TMP), Pyrimethamine
inhibits dihydrofolate reductase (decrease dTMP)
humans (methotrexate)
bacteria (trimethoprim)
protozoa(pyrimethamine)
5-fluorouracil (5-FU)
prodrug: capecitabine
forms 5-F-dUMP which inhibits thymidylate synthase (decrease dTMP) and decreases DNA synthesis
cancer drug
AR:handfoot syndrome (palmarplantar erythrodysesthesia)
allopurinol and febuxostat
Treatment for Lesch-Nyhan syndrome (HGPRT)
allopurinol which prevents hypoxanthine from becoming xanthine –> chronic gout tx
Or
febuxostat which prevents xanthine from becoming uric acid —> chronic gout tx
Actinomycin D
inhibits RNA polymerase in both prokaryotes and eukaryotes
Rifampin
inhibits DNA dependent RNA pol in prokaryotes
Quabain
cardiac glycoside that inhibits Na-K ATPase by binding to K site
digoxin and digitoxin
cardiac glycosides
inhibit the Na-K ATPase and indirect inhibition of Na/Ca exchange
increase in Ca concentrations
increased contractility
lumacaftor and ivacaftor
lumacaftor - corrects misfolded proteins and transport to cell surface
ivacaftor- opens Cl- channels
for CF
Fomepizole
FOMEpizole
inhibits alcohol dehydrogenase
For Overdose of Methanol or Ethylene Glycol
Disulfiram
DIScourage drinking by causing hangover
inhibits acetaldehyde dehydrogenase
acetaldehyde accumulates
Electron transport inhibitors
Directly inhibit electron transport
RotenONE inhibits complex I
Antimycin A inhibits complex III (an-THREE-mycin)
CyanIDE, carbon monoxIDE, axIDE (the “ides” –> 4 letters –> complex IV)
ATP synthase inhibitors
oligomycin
increases proton gradient and no ATP produced
Cyclosporine
immunosuppressant (Calcineurin inhibitor)
binds cyclophilin and blocks IL-2 transcription –> no T cell activation
use: prevent transplant rejection and inflammatory disorders
AR: metabolized by CYP 3A4 therefore avoid grapejuice, Highly NEPHROTOXIC, gingical hyperplasia, hirsutism
Tacrolimus
immunosuppressant (calcineurin inhibitor)
binds FK506 binding protein
Blocking T cell activation by preventing IL-2 transcription
use: prevent transplant rejection and inflammatory disorders
AR: NEPHROTOXIC and increased risk of diabetes
Sirolimus (Rapamycin)
Immunosuppressant and for kidney transplant rejection prophylaxis “kidney sir-vives”
AR: pancytopenia, not nephrotoxic
Basiliximab
immunosuppresant and for kidney transplant rejection prophylaxis
Blocks IL-2R
AR: edema, tremor, HTN
Azathioprine
Immunosuppresant
blocks lymphocyte proliferation by blocking nucleotide synthesis. “azathioPURINE”
degraded by xanthine oxidase
AR: panyctopenia
Mycophenolate
Mofetil
immunisuppresant
For lupus nephritis
inhibits IMP dehydrogenase –> preventing purine synthesis
Less nephrotoxic and neurotoxic
AR: pancytopenia, HTN, hyperglycemia
Glucocorticoids
immunosuppressant
Inhibits NFkB.
Decreasing transcription of many cytokines and induces T cell apoptosis
AR: cushings, osteoporosis, hyperglycemia, amenorrhea, peptic ulcers, psychosis, cataracts, avascular necrosis (femoral head).
Used to treat inflammation in graves opthalmopathy
Adrenal insufficiency may develop if drug is stopped abruptly after chronic use –> hypotension and shock
Epoetin alfa (EPO analog)
Bome marrow stimulation
Erythropoietin
used for anemia
especially in renal failure
can cause an increased risk of thromboembolic events and hypertension
Filgrastim (G-CSF)
Sargramostim (GM-CSF)
Bone marrow stimulation
Used for leukopenia
Romiplostim
Eltrombopag
Bone marrow stimulation
Romiplostim is a TPO analog
Eltrombopag is a TPO receptor agonist “Pag=bag for TPO”
Used for autoimmune thrombocytopenia
Aldesleukoin
Immunotherapy of IL2
increases activity of T cells and NKC
used for renal cell carcinoma and metastatic melanoma
IFN-α
immunotherapy of interferon
Used for chronic hep B and renal cell carcinoma
IFN-β
immunotherapy of interferon
used for multiple sclerosis
IFNγ
immunotherapy of interferon
used for chronic granulomatous disease
Alemtuzumab
Therapeutic antibodies
Targets CD52
Used for CLL (chronic lymphocytic leukemia) and MS
think: aLYMtuzumab
Bevacizumab
Therapeutic antibodies
Targets VEGF to inhibit angiogenesis
Used for colorectal cancer, renal cell carcinoma, non small cell lung cancer, treatment for wet age related macular degeneration
Cetuximab
Therapeutic antibodes
Targets EGFR –> decrease KRAS–> decreased cellular growth
Used for stafe 4 colorectal cancer and head/neck cancer
resistance due to mutation in KRAS that activates it
Rituximab
Therapeutic antibodies
Targets CD20
used for B cell non-hodgkin lymphoma, CLL, RA, ITP, multiple sclerosis
AR: progressive multifocal leukoencephalopathy
Trastuzumab
Therapeutic antibodies
Targets HER2
Breast cancer and gastric cancer
think HER2 –>tras2zumab
Adalimumab
Certolizumab
Golimumab
Infliximab
Autoimmune disease therapy
anti TNF α ( key mediatory in inflammatory process by accelerating neutrophil migration, macrophage phagocytosis, lymphocyte proliferation, cytokine synthesis)
Used for autoimmune disorders like IBD, RA, AS, psoriasis
AR: TB risk and drug induced lupus
Daclizumab
Autoimmune disease therapy
Targets CD25 (part of IL-2 receptor)
Used for relapsing MS
Eculizumab
Autoimmune disease therapy
Targets complement protein C5
Used for paroxysmal nocturnal hemoglobinuria
Natalizumab
targets α4 integrin which is important for WBC adhesion
USed for MS, crohns disease
Risk of PML in patients with JC virus
Ustekinumab
Targets IL12 and IL23
Used for psoriasis and psoriatic arthritis
Abciximab
targets platelet glycoproteins IIb/IIIa
used as an antiplatelet agent
Denosumab
mimics osteoprotegerin and targets RANKL
think DenOSumab affects OSteoclasts in OSteoporosis
Digoxin immune Fab
Targets Digoxin
antidote for digoxin toxicity ( yellow tinting seen on objects. REnally cleared with small therapeutic window
therefore increasing age –> decreased renal function –> increased risk of digoxin toxicity
high K+ is also a sign of digoxin toxicity
Omalizumab
refractory allergic asthma thats not responding to inhaled steroids and long acting beta2agonists
prevents IgE binding for FcERI
Palivizumab
Monoclonal antibody directed against the fusion protein of RSV. prevents infection of the host cell
used as RSV prophylaxis for high risk infants
think PaliVIzumab - VIrus
Penicillin
D-Ala-D-Ala structural analog
binds penicilin binding proteins (covalently binds transpeptidase) and blocks crosslinking of peptidoglycan cell wall
Used: Gram + organisms mostly, syphilis, spirochette
AR:hemolytic anemia and intersitital nephritis
Amoxicillin
Ampicillin
Aminopenicillins (amoxi is greater bioavailability)
MOA: same as penicillin but wider spectrum. Combine with clavulanic acid to pretoect against β-lactamase destruction (“they are AMPed up penicillins)
Used: Same as penicillin but wider spectrum
AR: pseudomembranous colitis, rash, hypersensitivity
Resistance: Penicillinase is a type of β-lactamase
Dicloxacillin
Nafcillin
Oxacillin
Penicillinase-resistant penicillins
MOA: bulky R group that blocks access of β-lactamase to β-lactam ring
Use: S aureus “naf for saph”
AR: hypersensitivity, interstitial nephritis
note: beta lactamase function degrade penicillin and cephalosporins
Piperacillin
Ticarcillin
Antipseudomonal penicillins
β-lactamase inhibitors
CAST
Clavulanic acid
Avibactam
Sulbactam
Tazobactam
Cephalosporins
MOA: β-lactam drugs that inhibit cell wall synthesis by irreversibly binding to penicillin binding proteins (i.e. transpeptidase)
note: same as penicillins
note: resistance forms by inhibiting the binding of ceftriaxone via changing the structure of the penicillin binding proteins
First generation cephalosporins
Cefazolin - prior to surgery to prevent S aureus
Cephalexin
2nd gen cephalosporins
Cefaclor
Cefoxitin
Cefuroxime
Cefotetan
3rd gen cephalosporins
Ceftriaxone
Cefotaxime
Cefpodoxime
Ceftazdime —> pseudomonas
can cross BBB therefore use Ceftriaxone for meningitis, gonorrhea, dissemniated lyme disease
note: add ampicillin when tx infant meningitis because if it is due to listeria then 3rd gen wont cover it due to it being intracellular
Cefepime
4th gen cephalosporins
gram (-) organisms with increased activity against pseudomonas and gram +
Ceftaroline
5th gen cephalosporin
Also covers Listeria, MRSA and enterococcus faecalis
does NOT cover pseudomonas
Doripenem
Imipenem
Meropenem
Ertapenem
Carbapenems - beta lactamase inhibitors
Imipenem is always given with cilastatin (an inhibitor of renal dehydropeptidase I) to decrease inactivation of drug in renal tubules
Meropenem is decreased risk of seizures and is stable to dehydropeptidase I
Use: LAST RESORT
AR: seizures at high plasma levels
Aztreonam
Monobactam
MOA: Binds to penicillin binding protein 3 and prevents cross linking.
Synergistic with animnoglycosides.
Use: if pt allergic to penicillin, in pt with renal insufficiency and cant handle aminoglycosides
Vancomycin
MOA: inhibits cell wall peptidoglycan formation by binding D-Ala-D-Ala
use: Gram + only , serious multidrug resistant organisms (i.e. s epidermidis)
AR: Nephrotoxicity, Ootoxicity, Thrombophlebitis, Diffuse flushing (Red man syndrome), eosinophilia and systemic symptoms (DRESS syndrome)
Gentamicin Neomycin Amikacin Tobramycin Streptomycin
Aminoglycosides
MOA: binding of the 30S subunit. requires O2 therefore ineffective against anaerobes. Also, pseudomonas is resistant by inactivating enzyme by acetylation or increasing efflux systems
Use: severe gram (-) rod infections because cant penetrate the cell wall of gram +. Therefore if want to treat gram + too then use with penicillin or some cell wall inhibitor
Neomycin for bowel surgery
AR: Nephrotoxicity, Neuromuscular blockade, Ototoxicity, teratogen
Tetracycline
Doxycycline
Minocycline
Tetracyclines
MOA: bind to 30S and prevent attachment of aminoacyltRNA
Note: Ca, antacids (Mg), Fe
Use: Doxycycline is fecally eliminated and can be used for pt with renal failure . Accumulates intracellularly –> good for intracellular organisms. For Acne and MRSA
AR: discoloration of teeth due to accumulation in dentin and enamel, inhibition of bone growth in children, photosensitivity, CONTRAINDICATED in pregnancy because crosses placenta
Tigecycline
Glycylcycline
MOA: Binds 30S
use: broad spectrum, multiresistant, and infections that require deep tissue penetration
AR: GI sx
Chloramphenicol
Blocks peptidyltransferase at 50S ribosomal subunit
use: Low cost but toxicity –> used in developing countries
AR: anemia (dose dependent aka reversible), APLASTIC ANEMIA (dose independent aka irreversible), gray baby syndrome (lack liver UDP glucuronosyltransferase), leukopenia, thrombocytopenia
Clindamycin
MOA: blocks 50S
use: anaerobic infections ABOVE the diaphragm in aspiration pneumonia, lung abcsess, and oral infections. Also invasive group A strep
AR: pseudomembranous colitis due to C diff
Linezolid
Oxazolidinones
MOA: binds to 50S subunit
USe: Gram + species including MRSA and VRE
AR: bone marrow suppression causes thrombocytopenia, peripheral neuropathy, SEROTONIN SYNDROME due to MAOI activity when used with SSRI
Azithromycin
Clarithromycin
Erythromycin
Macrolides
MOA: 23S rRNA of the 50S
Use: atypical pneumonias, STIs, gram + cocci, pertussis
AR: GI motility issues, prolonged QT interval, acute cholestatic hepatitis, eosinophilia.
Colistin (polymyxin E), polymyxin B
MOA: cation polypeptides that bind to phospholipids and disrupt cell membrane integrity
Use: salvage therapy for multidrug resistant gram - bacteria
Polymyxin B is part of a triple antibotic ointment
AR: nephrotoxicity, neurotoxicity, resp failure
Sulfamethoxazole (SMX)
Sulfisoxazole
Sulfadiazine
Sulfonamides
Inhibit dihydropteroate synthase in folate synthesis.
AR: tubulointerstitial nephritis, stevens johnson syndrome, kernicterus in infants
Dapsone
Similar to sulfonamides but structurally distint
use: Leprosy and prophylaxis for pneumocystis jirovecii
AR: hemolysis if G6PD deficient, methemoglobinemia
Trimethoprim
Inhibits bacterial dihydrofolate reductase
Used with sulfonamides to cause block of folate synthesis.
AR: Bone marrow effects like megaloblastic anemia, Leukopenia, granulocytopenia –> use folinic acid to avoid these
Ciprofloxacin
Enoxacin
Norfloxacin
Ofloxacin
Respiratory:
gemifloxacin
Levofloxacin
moxifloxacin
Fluoroquinolones
MOA: inhibit topo II (DNA gyrase) and topo IV.
DO NOT take with antacids
AR: contraindicated in pregnant women, nursing mothers, and children <18 yo due to possible damage to cartilage. May cause tendonitis or tendon rupture in people >60 yo and in patients taking prednisone.
Daptomycin
MOA: disrupts cell membranes of gram + cocci by creating transmembrane channels causing intracellular ion leakage leading to cell death
Use: MRSA, bacteremia, endocarditis, VRE
AR: myopathy and rhabdomyolysis
note: cant use for pneumo because inactivated by surfactant
Metronidazole
MOA: forms toxic free radical metabolites that damage DNA
Use: treats anaerobic infections BELOW the diaphragm. Can be used to replace amoxicillin for tx of H pylori if penicillin allergy. Bacterial vaginosis and trichomoniasis. GIARDIA
AR: severe flushing, metallic taste. disulfiram like reaction shrotly after ethanol consumption
Rifampin
Rifabutin
Rifamycins
MOA: Inhibits DNA dependent RNA pol
Use: TB, leprosy (use with dapsone to delay resistnace), meningococcal prophylaxis, chemoprophylaxis if in contact with kids with H influenza type b
AR: hepatotoxicity, red/orange body fluids, rapid resistance if used alone
Resistance: rapid resistance if monotherapy
Isoniazid
MOA: decrease synthesis of mycolic acid
Use: mycobacterium tuberculosis
AR: hepatotoxicity, p450 inhibition, drug induced SLE, anion gap metabolic acidosis, can cause sideroblastic anemia due to B6 synthesis def
NOTE: administer vitamin B6 with it because deficiency can cause peripheral neuropathy and sideroblastic anemia.
Pyrazinamide
prodrug of pyrazinoic acid
Works best at acidic pH
Use for mycobacterium tuberculosis
AR: hyperuricemia, hepatotoxicity
Ethambutol
MOA: decrease carb polymerization of mycobacterium cell wall by blocking arabinosyltransferase
use for mycobacterium tuberculosis
AR: optic neuropathy (red green colorblind). think “eyethambutol”
Streptomycin
MOA: interferes with 30S component of ribsosome
use: mycobacterium tuberculosis (2nd line)
AR: tinnitus, vertigo, ataxia, nephrotoxicity
Prophylaxis for high risk of endocarditis and undergoing surgical or dental procedures
amoxicillin
Prophylaxis for exposure to gonorrhea
Ceftriaxone
also give doxycycline and macrolides (azithromycin and eryhtromycin for chlamydia co infection)
Prophylaxis for history of recurrent UTIs
TMP-SMX
Prophylaxis for exposure to meningococcal infection
ceftriaxone, ciprofloxacin, or rifampin
Prophylaxis for women carrying group B strep
intrapartum penicillin G or ampicillin
Prophylaxis for prevention of gonococcal conjunctivitis in newborn
Erythromycin ointment on eyes
Prophylaxis for prevention of postsurgical infection due to S aureus
Cefazolin
Prophylaxis for strep pharyngitis in child with prior rheumatic fever
Benzathine penicillin G or oral penicillin V
Prophylaxis for exposure to syphilis
Benzathine penicillin G
Prophylaxis for HIV patients <200
TMP-SMX for pneumocystis pneumonia
Prophylaxis for HIV patients <100
TMP-SMX for pneumocystis and toxoplasmosis
Prophylaxis for HIV patient <50
Azithromycin or clarithromycin for mycobacterium avium complex
Amphotericin B
MOA: bind ergosterol
think B=binds to and “ amphoTEARicin “Tears” holes into fungal membrane”
“tears holes into kidney becuase nephrotoxic and allows changes in MG AND K (SIDE EFFECT)”
AR: Fever/chills, NEPHROTOXICITY due to vasoconstriction (supplement with K+ and Mg2+ and hydrate) –> hypokalemia and arythmias
Nystatin
Same as amphotericin B. Topical only because too toxic for systemic use
use: swish and swallow for thrush. topical for diaper rash and vaginal candidiasis
Flucytosine
MOA: inhibits DNA and RNA biosynthesis by conversion to 5-fluorouracil by cytosine deaminase
use: systemic fungal infetions in combination with ampho B (cryptococcal)
AR: bone marrow suppression
Clotrimazole Fluconazole Isavuconazole Itraconazole Ketoconazole Miconazole Voriconazole
Azoles
inhibiting conversion of lanosterol to ergosterol
use: local and serious systemic mycoses.
Fluconazole - cryptococcal meningiis in AIDS patients and candidal infections of all types
AR: testosterone synthesis inhibition (gynecomastia, ESPECIALLY with ketoconazole)
Terbinafine
MOA: inhibits the fungal enzyme squalene epoxidase
use: dermatophytes, especially onychomycosis
AR: GI, headache, hepatotoxicity, taste disturbance
Anidulafungin
Caspofungin
micafungin
Echinocandins
MOA: inhibit cell wall synthesis by inhibiting synthesis of beta glucan (major cellw all component is 1,3-BEta, D-glucan)
Use: invasive aspergillosis, candida
AR: GI upset, flushing (by histamine release)
Griseofulvin
MOA: interferes with microtubule function in keratin
Use: oral treatment of superficial infections. inhibits growth of dermatophytes
Adverse effects: teratogen, carcinogenic, icnrease cytochrom P450 and warfarin metabolism
Pyrimethamine
toxoplasmosis
Suramin
Melarsoprol
trypanosoma brucei
Nifurtimox
T cruzi
Sodium stibogluconate
leishmaniasis
Anti mite therapy used to tx scabies and mites
Permethrin- Inhibits Na channel deactivation –> neuronal membrane depolarization
Malathion- (acetylcholinesterase inhibitor)
Lindane- (blocks GABA channels –> neurotoxicity)
Chloroquine
MOA: blocks detoxification of heme into hemozoin. Heme accumulates and is toxic to plasmodia
P falciparum is resistant ( due to membrane pump that has decreased intracellular concentration of drug)
AR: retinopathy, pruritis especially in dark skinner people
Oseltamivir (tamiflu)
Zanamivir
MOA: sialic acid analog. Inhibit influenza A and B neuraminidase which decreases release of progeny virus (aggregates on host cell surface)
Beginning therapy within 48 hours
Why? normally newly formed virus particles initially remain attached to cells and respiratory tract mucins through hemagglutinin binding of glycoconjugate receptors. Neuraminidase cleaves the terminal sialic acid residues on these receptors and allows the release of attached virions and subsequent spread. Inhibition of neuraminidases prevents this
Acyclovir
Famciclovir
Valacyclovir (prodrug of acyclovir, more bioavailable)
MOA: guanosine analogs. Monophosphorylated by HSV/VSV thymidine kinase and not phosphorylated in uninfected cells –> few adverse effects. Preferentially inhibits viral DNA pol by incorporating into replicating viral DNA chain chain termination
AR: obstructive crystalline nephropathy and acute renal failure if not adequately hydrated
Ganciclovir
Guanosine analog.
5’-monophosphate formed by a CMV viral kinase. first line for CMV colitis
Triphosphate formed by cellular kinases that interferes with human host cell DNA synthesis
Prferentially inhibits viral DNA polymerase
AR: neutropenia. if combined with TMP-SMX will cause bone marrow suppression (TMP SMX inhibits tetrahydrofolic acid production)
Foscarnet
Viral DNA/RNA polymerase inhibitor and HIV reverse transcriptase inhibitor. Binds to pyrophosphate-binding site of enzyme. Does not require any kinase activation
think FOScarnet=pyroFOSphate analog
use: CMV retinitis or colitis when ganciclovir fails or acyclovir resistant HSV
AR: nephrotoxic and electrolyte abnormalities can lead to seizures due to chelation (hypomagnesia and hypocalcium )
Cidofovir
MOA: preferentially inhibits viral DNA polymerase. Does not require phosphorylation by viral kinase
use: CMV retinitis in immunocompromised patients; acyclovir resistant HSV
AR: nephrotoxicity
HAART therapy
Highly active antiretroviral therapy (HAART)
in HIV
3 drug regimen: 2 NRTIs and a integrase inhibitor
resistance in pol gene over time (resistance to protease inhibitors and transcriptase inhibitors)
Abacavir (ABC) Didanosine (ddl) Emtricitabine (FTC) Lamivudine (3TC) Stavudine (d4T) Tenofovir (TDF) Zidovudine (ZDV)
HIV - need to be phosphorylated to be active
nucleoside reverse transcriptase inhibitor which inhibitsvnucleotide binding and terminate the SNA chain (lack 3’OH)
all are nucleosides EXCEPT Tenofovir (think nucleoTide)
AR: bone marrow suppression, peripheral neuropathy, lactic acidosis due to nucleosides, anemia with ZDV, pancreatitis with ddl
ABC contraindicated in HLA B5701 mutation pt because of increase hypersensitivity risk
Delavirdine
Efavirenz
Nevirapine
for HIV
Bind to reverse transcriptase at site different from NRTIs. Does not require phosphorylation
AR: rash and hepatotoxicity are common. Efavirenz causes vivid dreams and other CNS symptoms. Delavirdine and efavirenz are contraindicated in pregnancy
Atazanavir Darunavir Fosamprenavir Indinavir Lopinavir Ritonavir Saquinavir
-navir = protease inhibitros which prevent maturation of new viruses by preventing cleavage of the polypeptide products of HIV mRNA into fxional parts
Ritonavir boost other drug concentrations by inhibiting cytochrome P450
AR: hyperglycemia due to insulin resistance, GI, lipodystrophy (chusing like syndrome and fat redistribution), nephropathy, hematuria, thrombocytopenia (indinavir),
Dolutegravir
Elvitegravir
Raltegravir
-tegravir = integrase inhibitors
Inhibits HIV genome integration into host cell chromosome by reversibly inhibiting HIV integrase
AR: increase in creatine kinase
Enfuvirtide
fusion inhibitor for HIV
binds gp41 and inhibits viral entry
think enFUvirtide inhibits FUsion
note: gp120 exoses underlying glycoprotein gp41 which mediates fusion
Maraviroc
fusion inhibitor for HIV
Binds CCR-5 (chemokine receptor on surface of T cells/monocytes to inhibit interaction with gp 120
think MaravirOC inhibits dOCking
Interferons
Interferons for HIV tx
MOA: glycoproteins normally synthesized by virus infected cells, exhibiting a wide range of antiviral and antitumoral properties
use: chronic HBV, HCV, kaposi sarcoma, hairy cell leukemia, condyloma cuminatum, renal cell carcinoma, malignant melanoma, MS, CGD
Adverse effects: flu like, depression, neutropenia, myopathy
HCV is treated via monotherapy or polytherapy?
polytherapy!
Ledipasvir
TX for HCV
viral phosphoprotein (NS5A) inhibitor
NS5A plays important role in replication
Ribavirin
TX for HCV and RSV
interferes with the duplication of viral genetic material
inhibits synthesis of guanine nucleotides by competitively inhibiting inosine monophosphate dehydrogenase
AR: hemolytic anemia and severe teratogen
Simeprevir
HCV protease (NS3/4A); prevents viral replciation
photosensitiviy reactions
Sofosbuvir
inhibits HCV RNA dependent RNA polymerase (NS5B) acting as a chain terminator
Antibiotics to avoid in pregnancy:
Sulfonamides Aminoglycosides Fluoroquinolones Clarithromycin Tetracyclines Ribavirin Griseofulvin chloramphenicol
Sulfonamides --> kernicterus Aminoglycosides --> ototoxicity Fluoroquinolones --> cartilage damage Clarithromycin --> embryotoxic Tetracyclines --> discolored teeth, inhibition of bone growth Ribavirin- teratogen Griseofulvin-teratogenic chloramphenicol - gray baby syndrome
Sympathetic G protein linked second messengers
alpha1 alpha2 beta1 beta2 beta3
alpha1 (q) –> vasoconstriction, mydriasis/dilation, sphincter mm contaction
alpha2 (i) –> decrease sympathetic (adrenergic) outflow, decrease insulin, lipolysis etc
beta1 (s) –> 1 heart (increased contractility)
beta2(s) –> 2 lungs ( bronchodilation etc)
beta3 (s) –>thermogenesis in skeletal mm and bladder relaxation
“qisss”
Parasympathetic G protein linked second messengers
M1
M2
M3
M1 (q) –> higher cognition and enteric NS
M2 (i) –> decrease HR and contractility
M3 (q) –> increase exocrine, gut peristalsis, bladder cotnraction, bronchoconstriction etc
Dopamine G protein linked second messengers
D1
D2
D1 (s) –> relaxes renal vascular smooth mm
D2 (i) –> modulates NT release in brain
Histamine G protein linked second messengers
H1
H2
H1 (q) –> nasal and bronchial mucus production, pruritis etc.
H2 (s) –> increase gastric acid secretion
Vasopressin G protein linked second messengers
V1
V2
V1 (q) –> increase vascular smooth mm contraction
V2(s) –> aquaporin2
Gq
–> phospholipase C–> eventually protein kinase C –> increases [Ca] –> smooth mm contraction
Gs and Gi
Gs –> + adenylyl cyclase –> ATP becomes cAMP –> protein Kinase A –> increase [Ca] in heart and inhibits myosin light chain kinase (smooth mm)
Gi –> (-) adenylyl cyclase
Amphetamine MOA
They use Noradrenergic nerve endings
1) use NE transporter to enter presynaptic terminal
2) use vesicular monoamine transporter (VMA) to enter neurosecretory vesicles
3) NE displaced from vesicle
4) presynaptic threshold
5) expelled
6) drug effects
Cholinomimetic agents
enhance the PNS
watch for exacerbations of COPD, asthma, and peptic ulcers in susceptible patients
Bethanechol
Direct agonists (cholinomimetic agents)
activates bowel and bladder smooth mm
resistant to AChE
Carbachol
Direct agonists (cholinomimetic agents)
carbon copy of acetylcholine but resistant to AChE
Use for contricting pupil and relieving intraocular pressure in open angle glaucoma
Methacholine
Direct agonists (cholinomimetic agents)
stimulate muscarinic receptors in airway
for dx of asthma (methacholine challenge beacause it constricts the bronchioles and increases mucus productions –> further illicit asthma smyptoms)
good for patients with asthma signs but normal spirometery test
Pilocarpine
Direct agonists (cholinomimetic agents)
potent stimulator of swear, tears, and saliva
Resistant to AChE and crosses BBB
open angle (Contracts ciliary mm of eye) and (Contracts pupillary sphincter) closed angle glaucoma, xerostomia (sjogren syndrome)
Donepezil
Rivastigmine
Galantamine
Indirect agonists (anticholinesterases)
increases ACh
used for alzheimers dz
Endrophonium
Indirect agonists (anticholinesterases) increase ACh
in past it was used to dx myasthenia gravis
Neostigmine
Indirect agonists (anticholinesterases) increase ACh
“neo” think No CNS penetration
used for myasthenia gravis, or NMJ blockade etc
Physostigmine
Indirect agonists (anticholinesterases) increase ACh
think phreely crosses BBB (only one that penetrates CNS and PNS)
antidote for anticholinergic toxicity from atropine overdose
Pyridostigmine
Indirect agonists (anticholinesterases) increase ACh
increases mm strength
think pyRIDostiGMine - gets RID of Myasthenia Gravis
does not penetrate CNS
Cholinesterase inhibitor poisoning
usually due to organophosphates which irreversibly inhibit AChE. Antidote is atropine a competitive inhibitor +pralidoxime which regenerates AChE if given early
atropine does not address the nicotinic effects of (mm weakness, paralysis, fluctuations) therefore must add pralidoxime
Atropine
Homatropine
Tropicamide
Muscarinic agents
eye
mydriasis and cycloplegia
Atropine is a competitive muscarinic receptor antagonist that opposes the effects of acetylcholine resulting in decreased muscle contraction intensity
Benztropine
Trihexyphenidyl
Muscarinic agents
CNS
parkinsons dz and acute dystonia related to antipsychotics
“park my benz”
Glycopyrrolate
Muscarinic agents
GI and resp
preop to reduce airway secretions
Hyoscyamine
Dicyclomine
Muscarinic agents
GI
antispasmodics for IBS
Ipratropium
tiotropium
Muscarinic agents
Resp
COPD, asthma
“I pray to breathe soon”
Oxybutynin
Solifenacin
Tolterodine
Muscarinic agents
GI
reduce bladder spasms and urge urinary incontinence
Scopolamine
Muscarinic agents
CNS
motion sickness
Atropine
Muscarinic antagonist (blocks M2)
increase in HR without affecting BP
used to tx bradycardia by decreasing vagal influence on AV and SA node and for ophthalmic applications
risk of glaucoma due to increased intraocular pressure and angle closure
blocks DUMBBELSS
AR: hot as a hare, Dry as a bone, red as a beet, blind as a bat, mad as a hatter, full as a flask. Can cause acute angle closure glaucoma in elderly due to mydriasis. Urinary retention in men with prostatic hyperplasia
Albuterol
Salmeterol
Terbutaline
Sympathomimetics with B2>B1
Albuterol –> acute asthma or COPD
Salmeterol –> long term asthma or COPD
Terbutaline –> acute bronchospasm in asthma and tocolysis
Dobutamine
Sympathomimetics with B1>B2 and alpha
HF, cardiogenic shock, cardiac stress testing
Dopamine
Sympathomimetic with D1=D2>B>A
unstable bradycardia, HF, shock
Alpha effects at high doses
Beta effects at low doses
Epinephrine
Sympathomimetics
B>A
anaphylaxis, asthma, open angle glaucoma, alpha effects predominate at high doses
AR: limits insulin use by insulin sensitive tissues and stimulates hepatic glycogenolysis and gluconeogenesis (like glucagon)
Isoproterenol
Sympathomimetics
Beta1=Beta2
eval of tachyarrhythmias. worsens ischemia
Midodrine
Sympathomimetics
alpha1
autonomic insufficiency and postural HTN
Mirabegron
Sympathomimetics
Beta3
urinary urge incontinence or overactive bladder
“Mira begs ron” to get out of the bathroom”
Norepinephrine
Sympathomimetics
alpha1>alpha2>Beta1
Hypotension and septic shock
reflex bradycardia
Phenylephrine
Sympathomimetics
alpha1>alpha2
hypotension (vasoconstrictor), ocular procedures because mydriatic, rhinitis (decongestant), ischemic priapism
Amphetamine
indirect Sympathomimetics
indirect general agonist, reuptake inhib, releases stored catecholamines
good for ADHD, narcolepsy, obesity
Cocaine
indirect Sympathomimetics
indirect general agonist, reuptake inhib
vasodilation and local anesthesia
dont give beta blocks with it because can lead to unopposed alpha1 activation which can cause extreme HTN and coronary vasospasm
Ephedrine
indirect Sympathomimetics
indirect general agonist and releases stored catecholamines
for nasal decongestion (pseudoephedrine), urinary incontinence, hypotension
Clonidine
Guanfacine
Sympatholytics (alpha2 agonists)
used for hypertensive emergency, ADHD, Tourette syndrome, opioid withdrawal
AR: CNS depression, bradycardia, hypotension, resp depression, miosis, rebound hypertension with abrupt cessation
alpha-methyldopa
Sympatholytics (alpha2 agonists)
first line for HTN in pregnancy
AR: direct coombs + hemolysis, drug induced lupus
Tizanidine
Sympatholytics (alpha2 agonists)
Relief of spasticity, especially in MS
“TICanadine”
AR: Hypotension, weakness, xerostomia
Phenoxybenzamine
Nonselective alpha blocker
Irreversible. Used for pheochromocytoma (preop) to prevent catecholamine (Hypertensive) crisis
AR: ortho hypotension and reflex tachy
Phentolamine
Nonselective alpha blocker
Used for epinephrine reversal
Reversible. Give to pt on MAO inhibitors who eat tyramine containing foods and for severe cocaine induced HTN
AR: ortho hypotension and reflex tachy
Prazosin
Terazosin
Doxazosin
Tamsulosin
alpha1 selective antagonist “osin”
decreases arteriole and venous resistance and decreases the tone of urinary sphincters.
used for urinary sx of BPH
Prazosin can be used for PTSD
Hypertension except for tamsulosin
AR: ORTHOSTATIC HYPOTENSION and vertigo. “first dose” syncope
Mirtazapine
alpha 2 selective antagonist, potent 5HT2 and 5HT3 receptor antagonist and H1 antagonist
used for depression (atypical antidepressant)
AR: increased serum cholesterol, increased appetite, weight gain, dry mouth
Acebutolol Atenolol Betaxolol Bisoprolol Carvedilol Esmolol Labetalol metoprolol Nadolol Nebivolol pindolol propanolol timolol
Beta blockers
decrease HR and contractility and ultimately O2 consumption
-Timolol - Glaucoma to decrease aq humor production
-Propanolol for symptom control of Hyperthyroidism
used for HTN by decreasing CO and DECREASES RENIN SECRETION
- Metoprolol and esmolol for supraventricular tachycardia by decreasing AV conduction velocity (class II antiarrhythic)
- Nadolol, propranolol, carvedilol for variceal bleeding by decreasing hepative venous pressure gradient and portal HTN
also for hypertrophic cardiomyopathy (decrease HR, increase fill time, relieve obstruction) and for decreasing mortality from MI
AR: erectile dysfunction, brady, AV block, HF, seizures, sleep problems, dyslipidemia (metoprolol), and asthma/COPD exacerbation. HYPOGLYCEMIA because hides signs and symptoms that blood sugar is low (palpitations, tremor)
B1 selective blockers
think 1st half of the alphabet (all the ones that are A to M)
. With the exception of carvedilol and labetalol
acebutolol(partial),atenolol, betaxolol,bisoprolol,esmolol,metoprolol
Nonselective blockers
think 2nd half of the alphabet (N to Z)
B1=B2
nadolol,pindolol (partial), propranolol, timolol
Nonselective alpha and B antagonists
Have a different suffix of “-ilol and alol”
carvedilol
labetalol
This beta blocker combines B1 adrenergic blockade with stimulation of B3 receptors
Nebivolol
increases NO
activates NO synthase in the vasculature and decreases systemic vascular resistance
Drugs to avoid according to the beers criteria
alpha blockers due to increased risk of hypotension
anticholinergics, antidepressants, antihistamine, opiods
Benzodiazepines
NSAIDs
PPIs (increased risk of c diff
Treatment for HTN with DM
ACEi and ARBs are protective against diabetic nephropathy
Treatment for HTN with asthma
ARBs
CA channel blcokers
Thiazide diuretics
selective Beta blockers (avoid nonselective to prevent B2 receptor induced bronchocontriction)
avoid ACEi to prevent confusion between drug or asthma related cough
Treatment for HTN in pregnancy
Hydralazine
Labetalol
Methyldopa
Nifedipine
Amlodipine Clevidipine Nicardipine Nifedipine Nimodipine Diltiazem Verapamil
note: dihydropyridines act on arterial smooth mm and are nifedipine, amlodipine, felodipine
note: nondihydropyridines affect the myocardium and are verapamil and diltiazem
“-dipine”
Block voltage dependent L type calcium channels of cardiac and smooth mm
nimodipine (dihydropyridine that acts on vascular smooth mm) –> subarachnoid hemorrhage by preventing cerebral vasospasm.
All other dihydropyridines are for HTN, angina, raynauds
Verapamil (nondihydropyridines that act on the heart, think V=Ventricles) –> HTN, angina, a fib/flutter
amlodipine and nifedipine best for vascular smooth muscle but cause PERIPHERAL EDEMA
Nicardipine and clevidipine is used fot HRN urgency and emergency
Hydralazine
MOA: increase cGMP –> smooth mm relaxation which vasodilates arterioles > veins.
Afterload reduction
Treatment of hypertensive emergency
Clevidipine fenoldopam labetalol nicardipine nitroprusside
Nitroprusside
short acting
increases cGMP via direct release of NO. Can release and cause cynaide toxicity
Fenoldopam
Dopamin D1 receptor agonist - coronary, peripheral, renal, and splanchnic vasodilation
decrease BP and increase natriuresis
use post op as antihypertensive
Nitroglycerin
Isosorbide dinitrate
Isosorbide mononitrate
Nitrates
vasodilate by increasing NO in vascular smooth mm –> increase in cGMP and smooth mm relaxation
Dilates veins»_space;>arteries and decreases preload
use: angina, acute coronary syndrome, pulmonary edema
AR: reflex tachy that can be prevented with beta blockers, tolerance can develop, severe headaches, cutaneous flushing, hypotension
contraindicated in right ventricular infarction (due to reduced preload and CO), hypertrophic cardiomyopathy (due to increased outflow tract obstruction), and those on PDE inhibitors (synergy causes increase in risk of severe hypotension)
Ranolazine
inhibits the late phase of sodium current thereby reducing diastolic wall tension and oxygen consumption. No effect on HR or contractility
use: angina refractory to other medical therapies
AR: QT prolongation
Milrinone
MOA: selective PDE3 inhibitor.
In cardiomyocytes: Increase cAMP–>increase Ca influx –> increase inotrophy and chronotropy
in vascular smooth mm: Increase cAMP –> inhibition of MLCK activity –> general vasodilation
used for short term in acute decompensated HF
AR: arrhythmias, hypotension
Lovastatin
Pravastatin
HMG-CoA reductase inhibitors that increases HDL but decreases TGs and LDL
MOA: inhibit conversion of HMG-CoA to mevalonate a cholesterol precursor. This results in upregulation of LDL receptors to increase uptake of circulatin LDL
AR: hepatotoxicity and myopathy(serum creatinine kinase 10xnormal limit). If used with erythromycin there is inhibition of CYP 3A4 and will result in acute renal failure
Cholestyramine
Colestipol
Colesevelam
Bile acid resins that prevent intestinal reabsorption of bile acids; liver must use cholesterol to make more. Decreases LDL, increases HDL, increases TG (hypertriglyceridemia)
AR: decreases absorption of drugs and fat soluble vitamins
Ezetimibe
prevents cholesterol absorption at small intestine brush border
Decreases LDL, increases or nothing for HDL, Decreases or nothing for TG
Gemfibrozil
Bezafibrate
Fenofibrate
Fibrates
Decreased hepatic VLDL production and
upregulate LPL –> increase TG clearance
Activates PPAR alpha to induce HDL synthesis
AR: MYOPATHY WHEN USED WITH STATINS, cholesterol gallstones due to inhibition of cholesterol 7alpha-hydroxylase
Niacin (B3)
MOA: inhibits lipolysis (hormone sensitive lipase) in adipose tissue; reduces hepatic VLDL synthesis and TGs
AR: red flushed face, hyperglycemia, hepatotoxic, hyperuricemia(acute flare of gouty arthritis) due to decreased renal excretion of uric acid
Alirocumab
Evolocumab
PCSK9 inhibitors
MOA: inactivation of LDL receptor degradation, increasing amount of LDL removed from bloodstream
AR: myalgias, delirium, dementia, other neurocognitive effects
digoxin
Cardiac glycosides
MOA: direct inhibition of Na/K ATPase (decreased Na efflux)–> indirect inhibition of Na/Ca exchanger (decreased Ca efflux)–> increase Ca concentrations –> positive inotropy. It also stimulates vagus neve –> decrease in HR
Use: Increase contractility in HF, decrease conduction in AV node and also depress SA node for a fib. Can be used for a fib
AR: cholinergics side effects, hyperkalemia (poor prognosis), life threatening cardiac dysrhythmia
note: patients with hypokalemia have higher risk of toxicity because available spots on Na/K ATPase for digoxin to bind ( classic drug interaction between digozin and loop diuretics)
antidote: normalize K+ and give anti-digoxin Fab fragments, Mg
Class I antiarrhythmics
slow or block conduction (esp in depolarized cells)
decrease phase 0 slope
selectively depress tissues that are frequently depolarized
Class IA antiarrhythmics
Quinidine
Procainamide
Disopyramide
Increase AP duration, effective refractory period, QT interval
Used for atrial and ventricular arrhythmias
AR: chinchonism (headache,tinnitus with quinidine), reversible SLE like syndrome with procainamide, HF with disopyramide. Thrombocytopenia and torsades
Lidocaine
Mexiletine
Class IB antiarrhythmics (can include phenytoin)
Decrease AP duration. Prefers depolarized or ischemic tissue, has little effect on normal cardiac tissue
Used for post MI acute V arrhythmias and digitalis induced arrhythmias
AR: CNS stimulation/depression, CV depression
Flecainide
Propafenone
Class IC antiarrhythmics
MOA: prolongs ERP in AV node and accessory bypass tracts ONLY
Use: SVT, a fib, last resort for refractory VT
AR: proarrhythmic, contraindicated post-MI and structural or ischemic heart disease
Metoprolol Propranolol Esmolol (very short acting) Atenolol Timolol Carvedilol
note: b1 is in renal and cardiac but not smooth mmemes
Antiarrhythmics - (class II) - Beta blockers
MOA: decrease SA and AV nodal activity by decreasing cAMP, Ca currents. Decreases slope of phase 4
Use: SVT, Ventricular rate control for a fib and a flutter
AR: impotence, COPD and asthma exacerbation, sedation, may mask signs of hypoglycemia.
Metoprolol can cause dyslipidemia
Propranolol can exacerbate vasospasm in prinzmetal angina
Beta blockers can cause unopposed alpha1 agonism if given alone for pheochromocytoma or cocaine toxicity
Amiodarone
Ibutilide
Dofetilide
Sotalol
Antiarrhythmics - potassium channel blockers (Class III)
MOA: increase AP duration, ERP, QT interval
Use: A fib, a flutter and ventricular tachy (amiodarone and sotalol).
spells AIDS
AR:
- Sotalol: torsades, excessive beta blockade
- Ibutilide: torsades
Verapamil
Diltiazem
Antiarrhythmics - calcium channel blockers (class IV)
MOA: decrease conduction velocity, increase ERP, increase PR interval
use: prevent nodal arrhythmias and rate control in a fib
AR: flushing, PERIPHERAL EDEMA, HF, av block (negative chronotropic effect), sinus node depression, COSTIPATION, worsening Congestive HF in patients wiht reduced LV function due to negative inotropic effect
Adenosine
increase K+ out of cell which hyperpolarizes cell and decreases Ica –> decreases AV node conduction
for SVT/paroxysmal supraventricular tachycardia
very short acting. Theophylline and caffeine are adenosine receptor antagonists
AR: flushing, hypotension, chest pain, sense of impending doom, bronchospasm. CORONARY STEAL
Ivabradine
MOA: selective inhibition of funny sodium channels (If), prolonging slow depolarization (phase 4)
decreases SA node firing; negative chronotropic effect without inotropy. Reduces cardiac O2 requirement
Use: chronic stable angina in pt who cant take beta blockers and for chronic HF with reduced EF
AR: luminous phenomena/visual brightness, HTN, bradycardia
What do you give for torsades and digoxin toxicity
Mg 2+
What is first line drug for DM type 2
metformin
What type of insulin is preferred for DKA, hyperkalemia, stress hyperglycemia
Regular short acting insulin
Rapid acting insulin
1 hr peak
lispro
aspart
glulisine
there is no “LAG”
Short acting insulin
2 -3 hr peak
regular
intermediate acting insulin
4-10 hr peak
NPH
Long acting insulin
No real peak
detemir
glargine
Pramlintide
amylin analog
decreases glucagon release, gastric emptying
increases satiety
For DM management
Exenatide
Liraglutide
GLP 1 analogs
decrease glucagon release, gastric emptying
increase glucose dependent insulin release and satiety
AR: pancreatitis
commonly used to lose weight
“my ex lira lost weight”
For DM management
Metformin
Biguanides
inhibits mGPD to prevent hepatic gluconeogenesis and the action of glucagon. It increases glycolysis and peipheral glucose uptake
AR: lactic acidosis (caution in renal insufficiency), B12 deficiecny
promotes weight loss!
For DM management
Chlorpropamide
Tolbutamide
first generation sulfonylureas
close K+ channel in pancreatic beta cell membrane –> depolarization –> ca influx –> insulin release
For DM management
AR: hypoglycemia (increased risk with renal failure), weight gain, disulfiram like effects
Glimepiride
Glipizide
Glyburide
Second geneation sulfonylureas
close K+ channel in pancreatic beta cell membrane –> depolarization –> ca influx –> insulin release
AR: hypoglycemia (increased risk with renal failure) in the elderly, weight gain
For DM management
Nateglinide
Repaglinide
Meglitinides
close K+ channel in pancreatic beta cell membrane –> depolarization –> ca influx –> insulin release
BUT DIFFERENT BINDING SITE FROM SULFONYLUREAS
For DM management
AR: hypoglycemia (increased risk with renal failure), weight gain
Linagliptin
Saxagliptin
Sitagliptin
DPP-4 inhibitors
inhibit DDP4 enzyme that deactivated GLP-1.
For DM management: decrease in glucagon release, gastric emptying. Increase in glucose dependent insulin release, satiety
AR: urinay and resp infections
Pioglitazone
Rosiglitazone
For DM management by improving insulin sensitivity
works via alterations in gene transcription and activation and therefore takes few weeks to start working
PPAR gamma activator (intranuclear receptor)–> increases insulin sensitivity but upregulating GLUT 4 and levels of adiponectin(increases number of adipocytes sensitive to insulin)
AR: weight gain, water weight gain, increased risk of fractures
Canagliflozin
Dapagliflozin
Empagliflozin
Sodium glucose co transporter 2 (SGLT2) inhibitors
block reabsorption of glucose in proximal convoluted tubule
AR: glucosuria causes UTIs and vaginal yeast infection, hyperkalemia, dehydratiom, weight loss (check BUN and creatinine first)
Acarbose
Miglitol
inhibit intestinal brush border alpha glucosidases–> decrease postprandial hyperglycemia
AR: not recommended if kidney fx is impaired
Thioamides
Propylthiouracil
Methimazole
MOA: block thyroid peroxidases and blocks 5’-deiodinase ( decreased conv and creation)
Used for hyperthyroidism
PTU for first trimester prgnancy treatment because methimazole is a teratogen and cause aplasia cutis. Use methimazole in 2nd and 3rd due to risk of PTU induced hepatotoxicity.
note: agranulocytosis and consequent neutropenia is a serious complication of antithyroid drugs
Levothyroxine (T4)
Liothyronine (T3)
thyroid hormone replacement
used for hypothyroidism and myxedema
may be abused for weight loss
AR: similar to hyperthyroid sx
Conivaptan
Tolvaptan
ADH antagonists - blocks action of ADH at V2 in SIADH
Desmopressin
central DI, von willebrand disease, sleep enuresis, hemophilia A
helps central DI via adenylate cyclase
GH
GH deficiency
turners syndrome
Oxytocin
labor induction
milk letdown
controls uterine hemorrhage
Somatostatin (octreotide)
Acromegaly, carcinoid syndrome, gastrinoma, glucagonoma, esophageal varices
Demeclocycline
MOA: ADH antagonist (member of tetracycline family)
Used for SIADH
AR: nephrogenic DI, photosensitivity, abnormalities of bone and teeth
Fludrocortisone
MOA: synthetic analog of aldosterone with little glucocorticoid effects
Use: mineralocorticoid replacement in primary adrenal insufficiency
AR: hyperpigmentation, HF exacerbations, similar to glucocorticoids
Cinacalcet
MOA: sensitizes Ca sensing receptor (CaSR) in parathyroid gland and decrease PTH
“Cin-sitive for Calc-ium”
Used for refractory hypercalcemia
Sevelamer
MOA: nonabsorbable phosphate binder that prevents phosphate absorption from the GI tract
Use: hyperphosphatemia in CKD
AR: hypophosphatemia
“SEVER ABS OF LAME PHOSPHATE IN GI”
Cimetidine
Ranitidine
Famotidine
Nizatidine
Histamine 2 blockers for acid suppression
AR: antiandrogenic effects (proalctin release, gynecomastia, impotence, decreased libido in males), crosses BBB and placenta, cimetidine multidrug interactions
“tidine” sounds like “histamine”
Omeprazole Lansoprazole Esomeprazole Pantoprazole Dexlansoprazole
Proton pump inhibitors
irreversibly inhibit H+/K+ ATPase
AR:
1) increased risk of c diff
2) Decrease in Mg and Ca increases risk of fracture in elderly (osteoperosis)
Aluminum hydroxide unique side effects
antacid
constipation and hypophosphatemia
proximal mm weakness
osteodystrophy
seizures
“aluMINIMUM amount of feces”
Calcium carbonate unique side effects
antacid
AR: rebound acid increase
can chelate and decrease effectiveness of other drugs
Magnesium hydroxide unique side effects
antacid
diarrhea, hyporeflexia, cardiac arrest
MG= Must Go ….to bathroom
Bismuth
Sucralfate
binds to ulcer base, providing physical protection and allowing HCO3 secretion to reestablish pH gradient in the mucous layer
require acidic environment
good for ulcer healing and travelers diarrhea (bismuth)
“bisMOUTH of ulcer and SURFACE=SUCRALFATE”
Misoprostol
PGE1 analog : increases gastric mucous barrier and decreases acid production (reverses COX 1 inhibition effect of NSAID that induce peptic ulcer)
AR: contraindicated in women of childbearing potential because its abortifacient (MIScariage)
Octreotide
long acting somatostatin analog
used for acute variceal bleeds, acromegaly, VIPoma, carcinoid tumors
increased risk of cholelithiasis due to CCK inhibition
Sulfasalazine
a combo of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti inflammatory). activated by colonic bacteria
use: ulcerative colitis, crohns disease
AR: sulfonamide toxicity, reversible oligospermia
Loperamide
agonist at u-opioid receptors
low addictive potential (poor CNS penetration)
used for diarrhea
Ondansetron
5-HT3 antagonist,
central acting
used for postop vomiting and cancer chemotherapy vimiting
AR: QT prolongation
Metoclopramide
D2 receptor antagonist.
use: diabetic and post surgery gastroparesis,antiemetic, persistent GERD
AR: increase parkinsonian effects, tardive dyskinesia
contraindicated in patients with small bowel obstruction or parkinsons disease due to D2 receptor blockage
Orlistat
Inhibits gastric and pancreatic lipase to reduce the absorption of dietary fat
use: weight loss
AR: decreased absorption off fat soluble vitamins
aprepitant
substance P antagonist that blocks NK1 receptors in the brain
use: antiemetic for chemo induced
“a Prep for chemo nausea”
Psyllium
Methylcellulose
bulk forming laxatives
soluble fiber draws water into lumen
Magnesium hydroxide
Magnesium Citrate
Polyethylene glycol
Lactulose
Osmotic laxative
lactulose also treats hepatic encephalopathy: gut flora degrade lactulose into metabolites (lactic acid and acetic acid) that promote nitrogen excretion as NH4
Senna
Stimulants of enteric nerve cause colonic contraction
“Senna S-timulates EN-teric N-erves”
AR:melanosis coli
Docusate
Emollients
promotes incorporation of water and fat in stool
“Doc-U-SAid I have water and fat in my stool???”
AR: diarrhea
Cromolyn sodium
prevents mast cell degranulation (used for asthma prophylaxis)
Dimercaprol
EDTA
first line treatment for foot and wrist drop associated with lead poisonin
“is there LEAD in my DIME”
“MDMA abuse LEADS to drugs”
Succimer
chelation for kids with lead poisoning
“SUCks to be a kid who eats LEAD”
Heparin
MOA: activates antithrombin which decreases action of IIa (thrombin) and factor Xa.
Follow via PTT
Use: immediate anticoag . Does not cross the placenta
AR: heparin induced thrombocytopenia (HIT)
Heparin antidote
Protamine sulfate
“Herpes is (-) and needs (+) protamine”
Positively charged molecule that binds negatively charged heparin
Low molecular weight heparin
- enoxaparin
- dalteparin
activates antithrombin and acts mostly on factor Xa rather than IIa (thrombin)
2-4X longer half life than unfractionated heparin
BUT not easily reversible
Safe for pregnancy but switch to normal heparin at time of birth to prevent bleeding
Heparin induced thrombocytopenia (HIT)
antibody-heparin PF4 complex activates platelets –> thrombosis and thrombocytopenia
Direct thrombin inhibitors
Bivalirudin
Argatroban
Dabigatran (only oral agent)
Warfarin
MOA: interferes with gamma carboxylation of vitamin K dependent clotting factors (II, VII, IX,X, and protein C and S). Metabolism by vitamin K epoxide reductase complex (VKORC1).
in lab: increases PT
CANNOT use in pregnant women (teratogen) because lipid soluble and can cross the placenta. Heparin is safe because water soluble.
cytochrome p450 interaction with rifampin, phenobarbital, phenytoin, st johns wort which decrease anticoagulation
Why is there an initial risk of hyper coagualtion with warfarin? how can it be avoided?
protein C has a shorter half life than factors II and X. Existing protein C depletes before existing factors II and X deplete, and before warfarin can reduce factors II and X production –> hypercoagulation.
Tissue necrosis is due to small vessel microthrombosis
avoided via heparin bridging - use heparin when starting warfarin. Heparins activation of antithrombin enables anticoagulation during intitail, transient hypercoagulable state caused by warfarin.
How do you reverse warfarin
vitamin k
for rapid reversal give fresh frozen plasma (FFP) or PCC
“during the war there was blood and plasma everywhere”
ingestion of rat poison has same effects as warfarin overdose (brodifacoum)
Apixaban
Rivaroxaban
Direct factor Xa inhibitors
Use: DVT, PE, Stroke
AR: not easy reversible
Alteplase (tPa)
Reteplase (rPA)
Streptokinase
Tenecteplase (TNK-tPA)
Thrombolytics
MOA: plasminogen to plasmin which cleaves thrombin and fibrin clots. Increase PT and PTT because affects common pathway, no change in platelet count
AR: INTRACEREBRAL HEMORRHAGING
Clopidogrel
Prasugrel
Ticagrelor (reversible)
Ticlopidine
ADP receptor inhibitors (P2Y12) and inhibit platelet agGREgation (“-grel”). Prevent expression of glycoproteins IIb/IIIa
CLOPIDOGREL IS AS GOOD AS ASPIRIN. USE IF ALLERGIC TO ASPIRIN
AR: neutropenia (ticlopidine)
Cilostazol
Dipyridamole
MOA: phosphodiesterase inhibitors; increase cAMP in platelets, resulting in inhibition of platelet aggregation, vasodilators
Use: claudication, prevention of stroke or TIAs (combined with aspirin),
Adverse effects: facial flushing, CORONARY STEAL
Abciximab
Eptifibatide
Tirofiban
MOA: Bind to the glycoprotein receptor IIb/IIIa
Use: unstable angina, percutaneous coronary intervention
Cladribine
antimetabolites - cancer drug
MOA: purine analog
Use: Hairy cell leukemia “CLAN”
AR: myelosuppression, nephrotoxicity, and neurotoxicity
Cytarabine (arabinofuranoyl cytidine)
antimetabolites - cancer drug
MOA: pyrimidine analog –> DNA chain termination. At higher concentrations, inhibits DNA polymerase
Use: Leukemias (AML) and lymphomas
AR: megaloblastic anemia. CYTarabine causes panCYTopenia
Methotrexate
antimetabolites - cancer drug
MOA: folic acid analogy that competitively inhibits dihydrofolate reductase (results in accumulation of dihydrofolate polyglutamate)–> decrease dTMP –> decrease DNA synthesis. undergoes polyglutamination and accumulates in cells
USE: cancers, ectopic pregnancy, medical abortion, RA, psoriasis, IBD, vasculitis
AR: myelosuppression which is reversible with leucovorin “rescue”, pulmonary fibrosis, folate deficiency
Bleomycin
Antitumor antibiotics
MOA: induces free radical formation which causes breaks in DNA strands
Use: testicular cancer, hodkin lymphoma
AR: pulmonary fibrosis
Dactinomycin (actinomycin D)
Antitumor antibiotics
MOA: Intercalates into DNA, preventing RNA synthesis
Use: wilms tumor, ewing sarcoma, rhabdomyosarcoma. used for childhood tumors
Doxorubicin
Daunorubicin
Antitumor antibiotics
MOA: generate free radicals. Intercalate in DNA to create breaks in DNA and decrease replication. It interferes with topoisomerase II enzyme
Use: solid tumors, leukemias, lymphomas
AR: cardiotoxicity (dialted cardiomyopathy),
Dexrazoxane (iron chelating agent) used to prevent cardio toxicity
Busulfan
Alkylating agents
MOA: cross linsk DNA
Use: used to ablate patients bone marrow before bone marrow transplantation
AR: pulmonary fibrosis
Cyclophosphamide
Ifosfamide
Alkylating agents
MOA: cross link DNA at guanine, requires bioactivation by liver, a nitrogen mustard
Use: solid tumor, leukemia, lymphomas
AR: hemorrhagic cystitis, prevented with mesna (thiol group of mesna binds toxic metabolities) or adequate hydration
Nitrosoureas
Alkylating agents
MOA: requires bioactivation. Cross blood brain barrier to CNS. Cross links DNA
Use: brain tumors (including glioblastoma multiforme)
AR: CNS toxicity (convulsions, dizziness, ataxia)
Procarbazine
Alkylating agents
MOA: cell cycle phase - nonspecific alkylating agent,
Use: hodgkin lymphoma, brain tumors
AR: pulmonary toxicity
Paclitaxel
Other Taxanes
MOA: hyperstabilize polymerized microtubules in M phase so that mitotic spindle cannot break down (anaphase cannot occur)
Use: ovarian and breast carcinomas
“Taxes stabilize society”
Vincristine
Vinblastine
MOA: vinca alkaloids that bind beta tubulin and inhibit mitotic spindle formation (M phase arrest)
Use: hodgkin (vinblastine) and non hodgkin (vincristine) lymphomas
AR: Vincristine is neurotoxic (affects MT formation in axons) and causes peripheral neuropathy. It “crisps” the nerves
Vinblastine is bone marrow suppression. It blasts the bone marrow
Cisplatin
Carboplatin
MOA: cross link DNA
Use: Testicular, bladder, ovary, and lung carcinomas
AR: Nephrotoxicity, OTOTOXICITY
Prevent nephrotoxicity with amifostine (free radical scavenger) and chloride (saline) diuresis
Etoposide
Teniposide
MOA: inhibit topoisomerase II –> increases DNA degradation
Use: solid tumors (particularly testicular and small cell lung cancer), leukemias, lymphomas
AR: alopecia “ topoisomerase now needs two toupee”
Irinotecan
Topotecan
MOA: inhibit topoisomerase I
(He had 1 TEa CAN TO POur)
Use: Colon cancer (irinotecan), ovarian and small cell lung ancers (topotecan)
Erlotinib
MOA: EGFR tyrosine kinase inhibitor
Use: non small cell lung carcinoma
AR: rash
Imatinib
MOA: tyrosine kinase inhibitor of BCR-ABL (philadelphia chromosome fusion gnee in CML) and c-kit (GI stromal tumors)
Use: CML, GI stromal tumors (GIST)
AR: fluid retention
Bortezomib
Carfilzomib
MOA: proteasome inhibitors, induce arrest at G2-M phase and apoptosis
“zomibs inhibit the proteaZOMES”
Use: multiple myeloma, mantle cell lymphoma
AR: peripheral neuropathy, herpes zoster reactivation
Tamoxifen
Raloxifene
MOA: selective estrogen receptor modulatorys (SERMs) - receptor antagonists in breast and agonists in bone.
Use: breast cancer treatment (tamoxifen only, active metabolite is endoxifen) and prevention. Raloxifene also useful to prevent osteoporosis
AR: Tamoxifen - increase the risk of endometrial cancer because agonist effect in endometirum
Both increase risk of thromboembolic events
Vemurafenib
“VEmuRAF-enib” is for “V600E-MUtated bRAF INHIBition”
Use: metastatic melanoma
Rasburicase
MOA: recombinant urate oxidase that catalyzes metabolism of uric acid to allantoin
Use: prevention and treatment of tumor lysis syndrome (can also use allopurinol)
Common chemotoxicity: Cisplastin/Carboplatin
Ototoxicity
Nephrotoxicity
Common chemotoxicity: Vincristine
peripheral neuropathy
Common chemotoxicity: Bleomycin, Busulfan
pulmonary fibrosis
Common chemotoxicity: Doxorubicin
cardiotoxicity
Common chemotoxicity: Trastuzumab (herceptin)
cardiotoxicity
Common chemotoxicity: Cyclophosphamide
hemorrhagic CYstitis
Acetaminophen
MOA: REVERSIBLY inhibits COX mostly in CNS
instead of aspirin to avoid Reye syndrome in children
Aspirin
MOA: IRREVERSIBLY inhibits COX1 and COX2 by covalent acetylation that decreases synthesis of TXA2 and prostaglandins . This increases bleeding time without an effect on PT, PTT.
AR: gastric ulceration, tinnitus (CN VII), Reyes syndrome, aspirin exacerbated airway disease results from the dysregulation of arachidonic acid metabolis, due to COX inhibition (increased diversion of arachidoic acid down the 5-lipooxygenase pathway and reduced inhibition via prostaglandin E2). this results in increased formation of bronchoconstrictive leukotrienes
Celecoxib
MOA: Inhibits COX 2 for inflammation and pain. Spares Cox 1 and so helps maintain gastric mucosa and spares TXA2 production
use: RA, OA
AR: thrombosis, sulfa allergy
Ibuprofen Naproxen Indomethacin Ketorolac Diclofenac Meloxicam Piroxicam
NSAIDs
MOA: inhibit COX1 and COX2
Indomethacin is for PDA closure
Leflunomide
MOA: reversibly inhibits dihydroorotate dehydrogenase, preventing pyrimidine synthesis. suppresses T cell proliferation
Use: RA, psoriatic arthritis
AR: hepatotoxic and teratogen
Alendronate
Ibandronate
Risedronate
Zoledronate
Bisphosphonates “-dronate”
MOA: pyrophosphate analogs bind hydroxyapatite in bone, inhibiting osteoclast activitiy
Use: osteoporosis, hypercalcemia, paget disease of bone, metastatic bone disease, osteogenesis imperfecta
AR: esophagitis, osteonecrosis of jaw and femur
Teriparatide
MOA: recombinant PTH analog. Increase osteoblastic activity when administered in pulsatile fashion
Use: osteoporosis
AR: increased risk of osteosarcoma therefore avoid if pt has pagets disease of bone or unexplained elevation of alkaline phosphatase
Probenecid
Chronic gout
inhibits reabsorption of uric acid in PROximal convoluted tubule (also inhibits secretion of penicillin and enhances its efficacy)
can ppt uric acid calculi
Pegloticase
Chronic gout
recombinant uricase catalyzing uric acid to allantoin ( a more water soluble product)
NSAIDs+ Glucocorticoids +Colchicine
Acute gout drugs
careful with salicylates because it may decrease uric acid secretion
Colchicine works by binding and stabilizing tubulin to inhibit microtubule polymerization, impairing neutrophil chemotaxis and degranulation
Etanercept
TNF alpha inhibitor (decoy receptor for TNF alpha) –> impaired cell mediated immunity
Think “Etanercept intercepts TNF”
Use: RA, psoriasis, AS
AR: predisposition to infection and reactivation of latent TB because TNF is important in granuloma formation and stabilization. Drug induced lupus
Diazepam Lorazepam Triazolam Temazepam Oxazepam Midazolam Chlordiazepoxide
Benzodiazepines
MOA: Allosteric activation! GABAa action increased by increasing frequency of Cl- channel opening. Decreases REM sleep
Use triazolam or lorazepam for reduced day time somnolence while gapping SSRI therapy
AR: dependence, alcohol use dangerous, avoid other sedative drugs like first gen anithistiamines, less risk of resp and CV depression than barbs
Phenobarbital
pentobarbital
thiopental
secobarbital
Barbiturates - increase DURATions of Cl channel opening causes increased GABAa inihitory firing which decreases neuronal firing
use: sedative. thiopental specific for anesthesia
AR: resp and CV depression that can be fatal, CNS depression (worse with alcohol), CYP450 interactions
contraindicated in porphyria
Zolpidem
Zaleplon
Eszopiclone
Nonbenzodiazepine hypnotics
its Esz to ZZzzz
MOA: act on the BZ1 subtype of the GABA receptor. sleep cycle less affected compared to benzos
use: insomnia
Less dependence risk than benzos
Suvorexant
MOA: orexin (hypocretin) receptor antagonist
use: insomnia
contraindicated in patients with strong CYP3A4 inhibitors
Ramelteon
MOA: melatonin receptor agonist
Use: insomnia (safe in elderly)
AR: no dependence.nausea
Sumatriptan
triptans/dihydroergotamine
MOA: 5-HT 1B/1D agonist. inhibits the trigeminal nerve activation and prevents vasoactive peptide release; induce vasoconstriction
use: acute migraine or cluster headaches (for prophylaxis you can give verapamil)
AR: coronary vasospasm therefore contraindicated in patients with CAD or prinzmetal angina, serotonin syndrome, can cause hypertensive emergency
How do you treat overdose of benzo (also nonbenzo hypnotics)
flumazenil (competitive antagonist at GABA benzodiazepine receptor)
Benzo, barbs, and alcohol all bind the ____ receptor which is a ligand gated ____ channel
GABAa
Cl-
What benzo is safe to give for liver dz patients
Oxazepam
Temazepam
Lorazepam
What benzos have addictive potential
Alprazolam, riazolam,oxazepam, midazolam are short acting and therefore higher addictive potential
Parkinson disease drugs
due to loss of dopaminergic neurons and excess cholinergic activity
Bromocriptine, Amantadine, Levodopa with carbidopa, selegiline and COMT inhibitors, antimuscarinics
(BALSA)
Bromocriptine (ergot)
Pramipexole (non-ergot)
Ropinirole (non-ergot)
Dopamine agonists for parkinsons dz
AR: impulse control disorder, postural hypotension, hallucinations/confusion
bromocriptine also used for hyperprolactinemia
Amantadine
increase dopamine availability in parkinsons dz
increase release and decrease reuptake
AR: ataxia and livedo reticularis
Selegiline
Rasagiline
selective MAO type B inhib –> prevents dopamine conversion into DOPAC –> increase dopamine availability
prevent dopamine breakdown in parkinsons dz post-BBB (centrally)
used with L-DOPA but can increase adverse effects of L-DOPA
Entacapone
COMT inhibitor (central and peripheral)
blocks conversion of dopamine to 3-MT or methoxytyramine by inhibiting central COMT
prevents peripheral L-DOPA degradation to 3-O-methyldopa (3-OMD) by inhibiting COMT
used in conjunction with levodopa
Carbidopa/levodopa
DOPA decarboxylase inhibitor
carbidopa prevents peripheral conversion of L-DOPA to dopamine –> increase L-DOPA entering into CNS–> increase L-DOPA available for conversion to dopamine in the CNS
**dopamine cant cross BBB but L-DOPA can
AR: long term use can lead to dyskinesia or the “on-off” phenomenon, postural hypotension from increased production of catecholamines in periphery, increased central NS dopamine can cause severe anxiety and agitation
Tetrabenazine
Reserpine
MOA: inhibit vesicular monoamine transporter (VMAT) dopamine –> decreases vescile packaging and release
use: huntington chorea and tardive dyskinesia
Riluzole
MOA: decrease neuron glutamate excitotoxicity
use: ALS/Lou Gehrig disea
“riLOUzole”
Memantine
for alzheimers
think memantine=memory and time
moa: NMDA receptor antagonist; helps prevent excitotoxicity (mediated by Ca)
AR: dizziness, confusion, hallucinations
Desflurane Halothane Enflurane Isoflurane Sevoflurane Methoxyflurane N2O
Inhaled anesthetics
myocardia depression, resp depression, increased cerebral blood flow, decreased cerebral metabolic demand
AR: hepatotoxicity (halothane hepititis)
Nephotoxicity (methoxyflurane)
proconvulsant (enflurane, epileptogenic)
expansion of trapped gas in body cavity (N2O)
Thiopental
IV anesthetics
MOA: faciliatate GABAa by increasing duration
use: short surfical procedures
AR: decreased cerebral blood flow
high lipid solubility
Midazolam
IV anesthetics
MOA: facilitate GABAa by increasing freq
use: procedural sedation and anesthesia induction
AR: severe postop rresp depression, decreased bp, anterograde amnesia
Propofol
IV anesthetics
MOA: propentiates GABAa
use: rapid anesthesia induction due to lipophilic and accumulation in tissues with high blood flow, short procedures, ICU sedation
Ketamine
IV anesthetics
MOA: NMDA receptor antagonist
use: dissociative anesthesia
AR: increased cerebral blood flow, emergence reaction possible with disorientation, hallucination, vivid dreams
Procaine
Tetracaine
Benzocaine
Chloroprocaine
Ester local anesthetic (have one “I”)
MOA: block Na channels
if infected tissue then need more anesthetic because alkaline anesthetics are charged and cannot penetrate the acidic tissue
AR: CNS excitation, methemoglobinemia with benzocaine
Lidocaine
Mepivacaine
Bupivacaine
Ropivacaine
Amide local anesthetic (have two “I”)
given if allergic to esters
severe cardiovascular toxicity with bupivacaine
CNS drugs must be _____ soluble to cross the BBB or be actively transported
lipid soluble
Low solubility in blood for anesthetics
rapid induction and recovery times
High solubility in lipids for anesthetics
increased potency = 1/MAC
MAC= minimal alveolar conventration (of inhaled anesthetic) required to prevent 50% of subjects from moving in response to noxious stimulus
Malignant hypertension
inhaled anesthetics or succinylcholine induce fever and severe mm contractions
mutations in voltage-sensitive ryanodine receptor (RYR1 gene) cause increase Ca release from sarcoplasmic reticulum
treatment for malignant hypertension
dantrolene a ryanodine receptor antagonist
order of nerve blcokade
small diameter > large diameter
Myelianted > unmyelinated
size > myelination
small myelinated > small unmyelinated> large myelinated fibers > large unmyelinated fibers
loss (1) pain, (2) temp, (3) touch (4)pressure
Succinylcholine
depolarizing neuromuscular blocking drugs
MOA: strong ACh receptor agonist that produces a sustaine depol and prevents mm contraction
AR: hypercalcemia, SEVERE HYPERKALEMIA, malignant hyperthermia
Atracurium Cisatracurium pancuronium Rocuronium tubocurarine vecuronium
Nondepolarizing neuromuscular blcoking drugs
Dantrolene
MOA:prevents release of Ca from the SR of skeletal mm by binding to the ryanodine receptor
AR: malignant hyperthermia and neuroleptic malignant syndrome
Baclofen
MOA: skeletal mm relaxant as a GABAb receptor agonist in spinal cord
Use: mm spasticity due to MS or other, dystonia, ms
Cyclobenzaprine
MOA: skeletal mm relaxant acts within the CNS
Use: muscle spasms
AR: anticholinergic side effects. Sedation
Opiod analgesics
MOA: agonist at opioid receptors to modulate synaptic transmission- close presynaptic Ca channel, open postsynaptic K channels and decrease synaptic transmission. Inhibit release of ACH, NE, 5 HT, glutamate, substance P
Pentazocine
κ opioid agonist
μ opioid receptor weak antagonist or partial agonist
opioid withdrawal if also taking full opioid
Butorphanol
κ opioid receptor agonist and μ opioid receptor partial agonist
use: severe pain with less resp depression than full opioid agonists
AR: withdrawal thats not easily reversed with naloxone
Tramadol
very weak opioid agonist that also inhibits 5-HT receptors
use: chronic pain
adverse effects: similar to opiods. decreases seizure threshold. serotonin syndrome
Timolol
Betaxolol
Carteolol
Glaucoma drug - beta blcoker
decrease aq humor synthesis by epithelial cells
no pupilalry or vision changes
Epinephrine
Apraclonidine
Brimonidine
alpha blocker
decrease aq humor synthesis for glaucoma
mydriasis due to alpha 1 therefore do not use in closed angle glaucoma, ocular hyperemia, foreign body sensation, ocular pruritus
Acetazolamide
Glaucoma drug - diuretics
decrease aq humor synthesis via inhibition of carbonic anhydrase
no pupillar or vision changes
Bimatroprost
Latanoprost
Glaucoma drug - prostaglandins
first line
increase outflow of aq humor via decreased resistance of flow through uveoscleral pathway
Darkens color of iris (browning), eyelash growth
pilocarpine
carbachol
physostigmine
echothiophate
Glaucoma drug - cholinomimetics (M3)
Direct: pilocarpine, carbachol
Indirect: physostigmine , echothiophate
increase outflow of aq humor via contraction of ciliary mm and opening of trabecular meshwork
AR: miosis and cyclospasm
Use _____ in acute angle closure glaucoma because it is very effective at opening meshwork into canal of schlemm
pilocarpine, a cholinomimetic (M3)
Reversal of nondepolarizing neuromusuclar blocking drugs
i.e. side effect reversal due to tx of myasthenia gravis with cholinesterase inhibitors
neostigmine with atropine or glycopyrrolate
morphine, heroin, meperidine, methadone, codeine
full agonist -opioid
note: mu opioids like morphine cause contraction of smooth muscles in the sphincter of oddi leading to increased pressure in the common bile duct and the gallbladder
buprenorphine
partial agonist - opioid
Nalbuphine
pentazocine
mixed agonist/antagonist-opioid
Naloxone
Naltrexone
Methylnaltrexone
antagonist -opioid
which opioid is used for cough suppression
dextromethorphan
which opioid is used to tx diarrhea
-note: slows motility
loperamide
diphenoxylate
Opioid used for maintenance programs for heroin addicts
methadone
buprenorphine
naloxene
opioid toxicity tx? relapse prevention?
naloxone
naltrexone once detoxed
Benzodiazepines
first line for acute status epilepticus
MOA: increases GABAa action and postsynaptic chloride influx
Carbamzepine
commonly used for patial/focal seizures
also used for tonic clonic seizures
first line for trigeminal neuralgia
MOA: blocks Na channels
AR:blood dyscrasias(agranulocytosis, aplastic anemia due to bone marrow suppression), liver toxicity, teratogenesis, cytochrome P450, SIADH, steven johnsons syndrome
Ethosuximide
USe: absence seizures
MOA: blocks thalamic T type Ca channels
AR:urticaria, steven johnson syndrome
Gabapentin
used for partial focal seizures and peripheral neuropathy, postherpetic neuralgia
MOA: primarily inhibits high voltage activated Ca channels and designed as a GABA analog
Lamotrigine
USed for partial (focal), tonic clonic, abscence seizures
blocks voltage gated Na channels, inhibits the release of glutamate
AR: may cause stevel johnsons syndrome, titrate slowly
Levetiracetam
used for partial/focal and tonic clonic seizures
AR: neuropsychiatric symptoms
Phenobarbital
Used for partial(focal),tonic clonic, status epilepticus. First line in neonates “phenobabytal”
increases GABAa action
AR: dependence, cytochrome P450,cardioresp depression
Phenytoin
Fosphenytoin
first line for reccurrent status epilepticus
blocks Na channels
AR: P450, Hirsutism, enlarged gums, nystagmus, yellow brown skin, teratogen, osteopania, inhibited folate absorption, neuropathy, stevenjohnson,/dress syndrome, sLE like syndrome
Tiagabine
partial/tonic seizures
increase GABA by inhibiting reuptake
Topiramate
partial/focal and tonic clonic and fo rmigraine prevention
blocks Na channels and increases GABA action
AR: mental dulling, word finding difficulty, kidney stones, weight loss, glaucoma
Valproic acid
partial/focal, tonic clonic, abscence
increase Na channel inactivation, increase GABA concentration by inhibiting GABA transaminase
AR: GI distress, fatal hepatotoxicity, pancreatitis, neural tube defects, tremor, weight gain, contraindicated in pregnancy
Vigabatrin
for partial/focal
increase GABA, irreversible GABA transaminase inhibitor
vigaBATrin
Permanent visual loss –> BLACK BOX WARNING
first line for exlampsia seizures
MgSO4
Preferred med for: ADHD
stimulants - methylphenidate and amphetamines
Preferred med for: alcohol withdrawal
note: chronic alcohol consumption leads to decreased GABA sensitivity and alcohol tolerance develops. Abrupt cessation decreases inhibitory tone and results in CNS excitation (withdrawal)
Benzodiazepines
Preferred med for: bipolar disorder
Lithium, valproic acid, carbamazepine, lamotrigine, atypical antipsychotics
Preferred med for: bulimia nervosa
SSRI
Preferred med for: depression
SSRI
Preferred med for: general anxiety disorder
SSRI and SNRI
Preferred med for: OCD
SSRIs, venlafaxine, clomipramine
Preferred med for: panic disorder
SSRI, venlafaxine, benzodiazepine
Preferred med for: PTSD
SSRI
Preferred med for: social anxiety disorder
SSRIs, venlafaxine
perforamnce only: beta blockers and benzodiazepines
Preferred med for:Tourette syndrome
antipsychotics
Methylphenidate
Dextroamphetamine
Methamphetamine
CNS stimulants
MOA: increase catecholamine in the synaptic cleft, especially NE and dopamine
Use: ADHD and narcolepsy
AR: nervousness, agitation, anxiety, insomnia, tachycardia, hypertension, weight loss, tics
Typical antipsychotics
Haloperidol Primozide Trifluoperazine Fluphenazine Thioridazine Chlorpromazine
MOA: block dopamine D2 receptor (incrase cAMP)
High potency: Trifluoperazine, Fluphenazine, Haloperidol have more neuro side effects
Low potency: chlorpromazine, thioridazine have more anticholinergic and antihistamine and alpha1 blockade effects
AR:Lipid soluble and therefore stored in fat and slow to be removed from body
Major adverse effects of typical antipsychotics
Endocrine: dopamine receptor antagonism causing hyperprolactinemia –> galactorrhea, oligomenorrhea, gynecomastia
Metabolic: dyslipidemia, weight gain, hyperglycemia
Antimuscarinic: dry mouth and constipation
Antihistamine: sedation
Alpha1blcokade: orthostatic hypotension
Cardiac:QT prolongation
Ophthalmologic: chlorpromazine causes corneal deposits. Thioridazine causes retinal deposits. Neuroleptic malignant syndrome
Timeline of major adverse effects of typical antipsychotics
hours to days: acute dystonia
Days to months: akathisia (restlessness) and parkinsonism (bradykinesia)
Months to years: Tardive dyskinesia(orofacial chorea)
Aripiprazole Asenapine Clozapine Olanzapine Quetiapine Iloperidone Paliperidone Risperidone Lurasidone Ziprasidone
Atypical antipsychotics
MOA: most are D2 antagonists. Aripiprazole is D2 partial agonist
Use: schizophrenia positive and negative symptoms, Use Clozapine for tx resistant schizo or schizoaffective disorder and for suicidality in schizophrenia. Bipolar, OCD, anxiety disorder, depression, mania, tourette syndrome
AR: all cause a prolonged QT interval, fewer EPS and anticholinergic side effects than typical antipsychotics
Clozapine-agranulocytosis (monitor WBS) and seizures (dose related)
Risperidone- hyperprolactinemia (amenorrhea, galactorrhea, gynecomastia)
Olanzapine and clOzapine cause obesity and must have their metabolic perameters monitored for diabetes
Lithium
note: toxicity can occur if a patient takes thiazide diuretics, ACE I, and NSAIDS
Used as a mood stabilizer for bipolar disorder. Treat acute manic episodes and prevents relapse
AR: HYPOTHYROIDISM, EBSTEIN anomaly with heart, DIABETES INSIPIDUS by antagonizing vasopressin in the colelcting tubules(nephrogenic diabetes insipidus), Unwanted movements tremor
Fluoxetine Fluvoxamine Paroxetine Sertraline Escitalopram Citalopram
Selective Serotonin Reuptake Inhibitors
MOA: inhibit 5-HT reuptake
AR: fever than TCAs, GI distress, DIADH, sexual dysfunction (anorgasmia, decreased libido)
it takes 4-8 weeks to have an effect
Venlafaxine Desvenlafaxine Duloxetine Levomilnacipran Milnacipran
serotonin-norepinephrine reuptake inhibitors
MOA: SNRIs inhibit 5-HT and NE reuptake
AR: increase BP, stimulant effects, sedation, nausea
Tranylcypromine
Phenelzine
Isocarboxazid
Selegiline
Monoamine oxidase inhibitors
MOA: nonselective MAO inhibition increases levels of amine NT (norephinephrine, 5 HT, dopamine)
used for depression, anxiety, and parkinsons disease (selegiline)
AR: CNS stimulation; hypertensive crisis with tyramine ingestion (aged cheese, draft beer etc), contraindicated with SSRIs, TCAs, St Johns wort, meperidine, dextromethorphan (to prevent serotonin syndrome)
wait 2 weeks after stopping to start serotonergic drugs or stopping dietary restrictions
Amitriptyline Nortriptyline Imipramine Desipramine Clomipramine Doxepin Amoxapine
Tricyclic antidepressants
MOA: TCAs inhibit 5-HT and NE reuptake
Imipramine can also be used for nocturnal enuresis
AR: convulsions, coma, cardiotoxicity (due to arrhythmias from blocking fast sodium channel conduction) , respiratory depression, hyperpyrexia, confusion and hallucinations in the elderly due to anticholinergic side effects, URINARY RETENTION
use NaHCO3 to prevent arrhythmias
overdose treated with sodium bicarbonate
Methadone
opioid withdrawal and detox
long acting opiate used for heroin detox or long term maintenance therapy
Buprenorphine + naloxone
opioid withdrawal and detox
sublingual buprenorphine (partial agonist) is absorbed and used for maintence therapy
Naloxone (antagonist) is added to lower IV abuse potential
Naltrexone
opioid withdrawal and detox
Long acting mu opioid receptor blockade
given IM or as a nasal spray to treat acute overdose in unconscious individuals
relapse prevention once detoxified
ALSO FIRST LINE THERAPY FOR MODERATE TO SEVERE ALCOHOL ABUSE DISORDER. REDUCES CRAVINGS
Trazodone
Atypical antidepressant
Primarily blocks 5-HT2, alpha1adrenergic, and H1 receptors, also weakly inhibits 5-HT reuptake
Used for insomnia because high doses are needed for antidepressant effects
AR: sedation, nausea, priapism, postural hypotension, male specific side effects
Varenicline
Atypical antidepressant
Nicotinic ACh receptor partial agonist. Used for smoking cessation.
toxicity: sleep disturbances, may depress mood, Varenicline helps nicotine cravings decline
Vilazodone
Atypical antidepressant
inhibits 5-HT reuptake; 5- HT1A receptor partial agonist.
Used for major depressive disorders.
AR: headache, diarrhea, nausea, increased weight, anticholinergic effects. MAy cause serotonin syndrome if taken with other drugs
Vortioxetine
Atypical antidepressant
Inhibits 5-HT reuptake;
5HT1A receptor agonist
5HT3 receptor antagonist
Used for major depressive disorder
toxicity: sexual dysfunction, sleep disturbances (abnormal dreams), anticholinergic effects
Acetazolamide
MOA: carbonic anyhdrase inhibitor that causes self limited NaHCO3 diuresis and decreased total body HCO3 stores
Use: glaucoma, metabolic alkalosis, altitude sickness, pseudotumor cerebri, alkalinizes urine
AR: proximal renal tubular acidosis “ACIDazolamide”, paresthesias, NH3 toxicity, sulfa allergy, hypokalemia. Promotes calcium phosphate stone formation (insoluble at high pH)
Furosemide
Bumetanide
Torsemide
MOST POTENT diuretics
sulfonamide loop diuretics
MOA: inhibit cotransport system (Na/K/2Cl) of thick ascending limb of loop of henle. Abolish hypertonicity of medulla, preventing concentration of urine. Stimulate Prostaglandin E release (vasodilatory effect on afferent arteriole); inhibited by NSAIDs, increase Ca excretion
Use: edematous states, hypertension, hypercalcemia
AR: ototoxicity, Hypokalemia, Hypomagnesemia, Dehydration, Allergy (sulfa), metabolic alkalosis, Nephritis (interstitial), Gout
Ethacrynic acid
MOA: nonsulfonamide inhibitor at thick ascending limb of loop of henle
use: diuresis in patient allergic to sulfa drugs
AR: more ototoxic
“loop earing hurts your ear”
Thiazide diuretics
Hydrochlorothiazide
Chlorthalidone
Metolazone
moa: inhibit NaCl reabsorption in early DCT –> decreased Na and Cl –> decreased intravascular volume –> RAAS activation –> increased excretion of potassium and hydrogen (hypokalemia and metabolic alkalosis)
decreased diluting capacity of nephron and decreases Ca excretion (good for calcium oxalatae stone prevention and for osteoperosis)
AR: hypokalemic metabolic alkalosis (due to activation of RAAS) causing muscle weakness and cramps, hyponatremia, hyperglycemia (decreased isnulin and increased resistance), hyperlipidemia, hyperuricemia (increased resoprtion), hypercalcemia (increased resorption), sulfa allergy
Potassium sparing diuretics
Spironolactone
Eplerenone
Amiloride
Triamterene
MOA: spironolactone and eplerenone are competitive aldosterone receptor antagonists in cortical collecting tubule
Triamterene and amiloride block Na channels in the cortical collecting tubule
Use: Hyperaldosteronism, K depletion, HF, hepatic ascites (spironolactone), nephrogenic DI (amiloride) antiandrogen
AR: hyperkalemia (leads to arrhythmias), endocrine effects with spironolactone
Captopril
Enalapril
Lisinopril
Ramipril
Angiotensin converting enzyme inhibitors
inhibits ACE which decreases formation of ATII and decreases GFR by preventing constriction of efferent arterioles. This increases renin due to loss of negative feedback. Inhibition of ACE also prevents inactivation of bradykinin as potent vasodilator
Use: HTN, HF, proteinuria, diabetic nephropathy.
AR: cough, angioedema (due to increase in bradykinin therefore contraindicated in C1 esterase inhibitor deficiency), teratogen, increase creatinine ,
Use with caution in bilateral renal artery stenosis because ACEi will further decrease GFR and thus result in renal failure
Losartan
Candesartan
Valsartan
(ARBs)
MOA: selectively block binding of angiotensin II at AT1 receptor. Do not increase bradykinin
Use: HTN, HF, proteinuria, or chronic kidney disease
AR: hyperkalemia, decrease GFR, hypotension, teratogen
Aliskiren
Direct renin inhibitor, blocks conversion of angiotensinogen to angiotensin I.
Used for HTN
AR: hyperkalemia, decrease GFR, hypotension, angioedema. RElatively contraindicated in patients already taking ACE inhibitors or ARBs. Contraindicated in pregnancy
Leuprolide
MOA: GnRH analog with agonist properties when used in pulsatile fashion. Has antagonist properties when used in continuous fashion because it downregulates GnRH receptor in pituitary and thus decreases FSH and LH (initial rise in LH/testosterone and then decrease in testosterone)
Use: uterine fibroids, endometriosis, precocious puberty, prostate cancer, infertility
AR: hypogonadism, decreased libido, erectile dysfunction
“leuprolide in lieu of GnRH”
Ethinyl estradiol
DES
Mestranol
Estrogens
AR: clear cell adenocarcinoma of vagina in females exposed to DES in utero
Raloxifene
selective estrogen receptor modulator
antagonist at breast, uterus
agonist at bone
increases risk of thromboembolic events but no increased risk of endometrial cancer( vs tamoxifen)
used to treat osteoporosis
Anastrozole
Letrozole
Exemestane
Aromatase inhibitors
MOA: inhibit peripheral conversion of androgens to estrogen
Use:ER + breast cancer in postmenopausal women
Levonorgestrel Medroxyprogesterone Etonogestrel Norethindrone Megestrol
Progestins
MOA: bind progesterone receptors, decrease growth and increase vascularization of endometrium, thicken cervical mucus
Use: contraception, endometrial cancer, abnormal uterine bleeding.
Progestin challenge: presence of withdrawal bleeding excludes anatomic defects and chronic anovulation without estrogen
Mifepristone
Ulipristal
Antiprogestins
MOA: competitive inhibitors of progestins at progesterone receptors
Use: termination of pregnancy (mifepristone with misoprostol). Emergency contraception (ulipristal)
Copper intrauterine device
MOA: produces local inflammatory reaction toxic to sperm and ova, preventing fertilization and implantation, hormone free
AR: heavier or longer menses, dysmenorrhea.
Danazol
MOA: synthetic androgen that acts as partial agonist at androgen receptors
use: endometriosis, hereditary angioedema
AR: weight gain, edema, acne, hirsutism, masculinization, decrease HDL levels, hepatotoxicity, pseudo tumor cerebri
Testosterone
Methyltestosterone
MOA: agonist at androgen receptor
Use: treat hypogonadism and promote development of secondary sex characteristics. Stimulate anabolism to promote recovery after burn or injury
AR: Premature closure of epiphyseal plates. Increase LDL and decrease HDL
Tamsulosin
alpha1 antagonist used to treat BPH by inhibiting smooth mm contraction
selective for α1A/D receptors found on prostate vs vascular α1B receptors
Sildenafil
Vardenafil
Tadalafil
Phosphodiesterase type 5 inhibitors
MOA: increase in cGMP and thus prolonged smooth muscle relaxation in response to NO.
Use: erectile dysfunction, pulmonary hypertension, BPH (tadalafil)
“-fil” they “fill” the penis
AR: hot and sweaty, headache, heartburn, HTN
DO NOT USE WITH NITRATES BECAUSE BOTH ACT VIA cGMP AND CAUSE PROFOUND HYPOTENSION
Flutamide
Nonsteroidal competitive inhibitor at androgen receptors
used for prostate carcinoma
Ketoconazole
Inhibits steroid synthesis (inhibits 17,20 desmolase/17 alpha hydroxylase)
used in PCOS to reduce androgenic symptoms. can cause gynecomastia and amenorrhea
Spironolactone
Inhibits steroid binding, 17,20 desmolase/17alpha hydroxylase
used in PCOS to reduce androgenic symptoms. can cause gynecomastia and amenorrhea
Diphenhydramine
Dimenhydrinate
Chlorpheniramine
First generation histamine 1 blockers
reversible inhibitors of H1 histamine receptors
allergy, motion sickness, sleep aid
note: diphenhydramine can be used to treat neuroleptic malignant syndrome
AR: sedation, antimuscarinic, antiα adrenergic
Loratadine
Fexofenadine
Desloratadine
Cetirizine
Second generation histamine 1 blockers
use: allergy
AR: far less sedating that first gen because of decreased entry into CNS
Guaifenesin
expectorant
thins respirator secretions
does not suppress cough reflex
N-acetylcysteine
mucolytic - liquifies mucus in chronic bronchopulmonary disease by disrupting disulfide bonds
antidote for acetaminophen overdose
Dextromethorphan
Antitussive (antagonizes NMDA glutamate receptors)
synthetic codeine analog
has mild opioid effect when used in excess. Can cause serotonin syndrome if combined with other serotonergic agents
give naloxone if overdose
Pseudoephedrine
Phenylephrine
α adrenergic agonist used in nasal decongestants
Used to reduce hyperemia, edema, nasal congestion. Opens obstructed eustachian tubes
AR: hypertension. rebound congestion if used more than 4-6 days. can also cause CNS stimulation/anxiety (pseudoephedrine)
Bosentan
Endothelin receptor antagonists-pulmonary hypertension drugs
decrease in pulmonary vascular resistance
AR: hepatotoxic therefore monitor LFTs
Epoprostenol
Iloprostenol
Prostacyclin analogs-pulmonary hypertension drugs
PGI2 (prostacyclin) with direct vasodilatory effects on pulmonary and systemic arterial vascular beds
inhibits platelet aggregation
AR: flushing and jaw pain
Albuterol
Asthma drug - target inflammatory processes and parasympathetic tone
MOA: relaxes bronchial smooth mm via short acting beta1-agonist. Used during acute exacerbation
Salmeterol
Formeterol
Asthma drug - target inflammatory processes and parasympathetic tone
beta2agonist - long acting agents for prophylaxis of asthma symptoms
AR: tremor and arrhythmia
Fluticasone
Budesonide
inhaled corticosteroids
inhibit the synthesis of virtually all cytokines. Inactivate NF-KB, the transcription factor that induces production of TNF alpha and other inflammatory agents
first line therapy for chronic asthma
can cause oral thrush therefore use spacer or rinse mouth after use
Tiotropium
Ipratropium
Muscarinic antagonists
Asthma drug - preventing bronchoconstriction
used for COPD
Tiotropium is long acting
Zileuton
Antileukotrienes
5-lipoxygenase pathway inhibitor that blocks conversion of arachidonic acid to leukotrienes.
Hepatotoxic
Theophylline
Methylxanthines
causes bronchodilation by inhibiting phosphodiesterase and increasing cAMP levels due to decrease in cAMP hydrolysis
limited usage because there is a narrow therapeutic index (cardiotoxicity, neurotoxicity). SEIZURES and TACHYARYTHMIAS
metabolized by cytochrome P450
Blocks actions of adenosine
Cromolyn
Nedocromil
Mast cell stabilizers
Prevent release of inflammatory mediators from mast cells.
used for prevention of bronchospasm not for acute bronchodilation
Methacholine
nonselective muscarinic receptor (M3) agonist
used in brnchial challenge test to help diagnose asthma
This drug decreases hepatic synthesis of TGs and VLDL levels and reduces clearance of HDL but puts you at risk of developing acute gouty arthritis
Niacin
Class II antiarrhythmics antidote
tx overdose with saline, atropine, glucagon
First line treatment for wilsons disease
D-penicillamine which contains a free sulfhydryl group and functions as a copper chelator
first line treatment for lead poisoning
edate calcium disodium
increases urinary excretion of lead
first line treatment for iron overdose
deferoxamine
binds iron and converts it to ferroxamine which is water soluble form
first line treatment for cerebral toxoplasmosis
combination of pyrimethamine and sulfadiazine
along with leucovorin (folinic acid)
first line treatment for cerebral toxoplasmosis in someone with a sulfa allergy
pyrimethamine and clindamycin in case of sulfa drug hypersensitivity
along with leucovorin (folinic acid).
Antibiotics contraindicated in pregnancy
tetracyclines
Chloramphenicol
Trimethoprim/sulfamethoxazole
Aminoglycosides
Birth defect associated with tetracyclines
teeth staining
Birth defect associated with chloramphenicol
gray baby
Birth defect associated with trimethoprim/sulfamethoxazole
neural tube defects
Birth defects associated with aminoglycosides
ototoxicity
vestibulotoxicity
ACEi durigng pregnany
CONTRAINDICATED
causes renal anuria, impairs renal function, and oligohydramnios
What to give a patient with acute gouty arthritis that is in renal failure, has peptic ulcer disease, or cant take NSAIDS
colchicine which binds tubulin and prevents tubulin polymerization into microtubules. This impairs leukocyte migration and phagocytosis which decreases inflammation. But also neatively impacts GI mucosal cells MT formation
causes diarrhea, vomiting, nausea, abdominal pain
Erythropoiesis-stimulating agents (ESAs) side effects
erythropoietin
darbepoetin alpha
anemia of chronic kidney disease treatment
AR: thromboembolic events and hypertension
treatment for enterococcal endocarditis
aminoglycoside
prevents formation of 30s intiation complex by preventing binding of formylmethionine-tRNA
side effect for aminoglycosides
ototoxicity
nephrotoxicity
What antibiotic do you use to treat extended spectrum beta lactamse producing e coli
carbapenems
What is an adverse side effect of inhaled glucocorticoid use in asthma and how can you avoid it
oral cadidiasis
use spacer with inhaelr or oral rinse
What do you give a patient whose valsalva manuever hasfailed and for initial treatment of paroxysmal SVT
adenosine
treatment for giant cell arteritis
monoclonal antibody against IL6
tocilizumab
MEdications to avoid in patients with hypertrophic cardiomyopathy
Vasodilators because they decrease systemic vascular resistance (eg, dihydropyridine calcium channel blockers, nitroglycerin, and ACE inhibitors) and leading to decreased afterload and lower LV volumes.
Diuretics decrease LV venous filling (preload) and also result in greater outflow obstruction.
Patients with HCM have dynamic left ventricular outflow tract (LVOT) obstruction that worsens with decreased left ventricular (LV) volume (as can be caused by decreased preload and/or reduced systemic vascular resistance).
first line treatment for malaria
chloroquine
mefloquine is resistant
malaria drugs
chloroquine
mefloquine
tovaquone-proguanil artemisinins
P vivax and P ovale have dormant liver forms (hypnozoites) that require additional primaquine therapy.
aminoglycoside resistnace mostly due to
antibiotic modifying enzymes
add chemical groups to antibiotic and reduce ability to bind 16s ribosomal RNA within the 30S ribosomal subunit
Loop diuretics cause
ototoxicity
beta blocker overdose treatment
glucagon
activates g protein coupled receptors in cardiac myocytes –> + adenylate cyclase –> increase cAMP –> Ca release –> Sa node firing –> increases HR and cardiac contractility –> increase HR and BP in minutes
note: independent of adrenergic receptors
first line treatment for arsenic poisoning (insecticides )
Dimpercaprol
Immediate treatment for panic disorder
note: normal healthy patient comes in shaking and saying “I feel like im going to die” and with chest pain
benzodiazepines
long term treatment for panic disorder
SSRI/SNRI because takes weeks to take effect
what drugs ppt withdrawal in opiod addicts
partial agonists/antagonists
liek buprenorphine
what antihypertensive medication is good for someone with proteinuria
ACEi and ARBS
what seizure drug causes gingival hyperplasia
phenytoin
phenytoin adverse effects
Phenytoin toxicity is mainly characterized by CNS manifestations. Its effect on the cerebellum and vestibular system can cause ataxia and nystagmus.
Long-term therapy with phenytoin may cause gingival hyperplasia, coarsening of the facial features, and hirsutism.
Phenytoin interferes with the metabolism of folic acid and may cause megaloblastic anemia.
Phenytoin induces the P450 cytochrome oxidase system. It increases the metabolism—and therefore decreases the blood level—of many medications.
If taken during pregnancy, phenytoin may cause fetal hydantoin syndrome.
Most common adverse effect of statin use
myopathy
can also cause hepatotoxicity (check liver function)
IF patient has both absence and otnic clonic seizures
use valproate not ethosuximide
amiodarone
think amIODarone
30% iodine and can cause thyroid adverse effects (hypothyroid or hyperthyroid)
clozapine is for what kind of schizophrenia
treatment resistent (it has its CLOZ in your)
neutropenia and agranulocytosis are the major adverse effect. Seizures too
patients must have their neutrophil count continuosly measured
first line treatments for bipolar
First-line medications for bipolar maintenance treatment include lithium, the anticonvulsant valproate, and the second-generation antipsychotic quetiapine.
first line for narcolepsy
modafinil
valproate use during preganancy can cause
neural tube defects
Treatment for psoriasis that activates a nuclear transcription factor
calcipotriene
vitamin D analog that binds the vitamin D receptor and inhibits keratinocyte proliferation and stimulate keritinocyte differentiation
first line treatment for trigemnial nerualgia is
carbamazepine
AR: SIADH and boen marrow suprression (aplastic anemia)
treatment for lyme disease
early lyme: doxycyline
mid-late lyme: ceftriaxone
What vitamin supplementation do you give to a pt with measles
vitamin A
First line therapy for RA in DMARDS therapy
methotrexate
Isotretinoin
potent teratogen and absolutely ocntraindicated in pregnancy
requires a negative pregnancy test
Retinoids
Treatment for motion sickness
antimuscarinics (anticholinergics)
antihistamines
Treatment for chemotherapy induced emesis
dopamine receptor antagonists (D1)
Serotonin receptor antagonists
Neurokinin 1 receptor antagonists
5ht3 for GI upset
H1 and M1 for motion sickness/vergibo
D2 for emetogenic substances
Treatment of acute agitation and psychosis in delirium for elderly
haloperidol
“a halo because theyre old and close to the angels”
treatment for cryptococcal meningitis
ampho B and flucytosine
once pt stabilized do fluconazole
treatmment for restless leg syndrome
dopamine agonists
treat iron deficiency because can imapct dopamine pathway
treatment for cyanide toxicity due to nitroprusside
mitochondrial toxin that binds Fe3+ on cytochrome oxidase C inhibiting the electron transport chain
bright red venous blood and lactic acidosis
sodium thiosulfate is antidote (provides additional sulfur groupes for rhodanese enhancing CN detox)
rifaxamin
nonabsorbable antibiotic that alters GI flora to decrease intenstinal productiona nd absorption of ammonia
used with lactulose
treats hepatic encephalopathy
What to give ina spirochete infection
penicillin because gram - with peptidoglycan cell wall
treatment of acute intermittent poryphyria
glucose
hemin
causing down regulation of ALAS
preventing recurrnece of herpes outbreak via
daily valcyclovir, acyclovir, famciclovir
treat serotonin syndrome with
seretonin receptor antagonists like cyproheptadine
fidaxomicin
macrocyclic antibiotic
inhibits sigma subunit of RNA polymerase
for c diff
Why are the elderly prone to benzo side effects
increased volume of distribution secondary to decreased total body water, decreased total body mass, and increased body fat
reduced hepatic size and blood flow
Why does cocaine cause nasal perforation
vasal congestion
note: there is decreased REUPTAKE of NE, dopamine, and serotonin
Major amiodarone side effects
Amiodarone (Class I,II,III,IV effects)
INTERSTITIAL PNEUMONITIS
Hepatoxicitiy (check PFT, LFT, and TFTs),
Hypo/hyperthyroid
Acts as hapten (corneal deposits and blue/gray deposits resulting in photodermatitis).
ethylene glycol poisoning
flank pain
hematuria
oliguria
high anion gap metabolic acidosis
Drug that inhibit mTOR blocking cell cycle between the G1 to S phase to reduce smooth muscle cell proliferation over cardiac stents
everolimus
prevents neointimal hyperplasia and stent restenosis
Drugs that prolong the QT interval
Quinidine Procainamide Sotalol Amiodarone (LOWER RISK THAN OTHERS) Disopyramide Dofetilide Phenothiazine Tricyclic antidepressants
What antihypertensive drugs cause dyslipidemia in patients?
metoprolol and thiazides
How does phentolamine administration reverse the effects of epinephrine
Epinephrine is a nonselective alpha and beta adrenergic agonist that increases BP
administration of phentolamine, a nonselective alpha-antagonist, and then readministration of epinephrine will cause stimulation of only beta receptors. This will drop BP
The treatment of choice for pseudomonas pneumonia
double coverage with 2 or 3 of the following:
- antipseudomonal beta lactam (or aztreonam)
- aminoglycoside
- respiratory fluoroquinolone
How do beta blockers lower BP
- reducing myocardial contractility and heart rate
- decreasing renin release by the kidneys (regulated by B1 receptors in juxtaglomerular cells) which prevents conversion of angiotensinogen to angiotensin I
Adenosine and acetylcholine both have what effect on cardiac action potentials?
prolong phase 4 and reduce rate of spontaneous AP in pacemaker cells
Neprilysin
metalloprotease that inactivates several peptide hormones, including bradykinin, glucagon, enkephalins, and natriuretic peptides
All antidepressants carry a risk of inducing
mania in a susceptible patient (bipolar)
antidepressants should be stopped and a mood stabilizer inititated
Major side effect of bupropion
note: no weight gain or sexual side effects is a positive (does not affect serotonin)
INHIBITS REUPTAKE OF NE AND DOPAMINE
can cause seizures
avoid in patients that suffer from anorexia, bulimia, or seizure disorders
Treatment for enterobiasis due to E. vermicularis
Pinworm infection
first line is albendazole
second line In a pregnant patient is pyrantel pamoate
Treatment for drug induced parkinsonism
- give benztropine (anticholinergic will reduce ach) and increase Dopamine to ach ratio
- DO NOT give levodopa because will ppt psychotic features (i.e. if someone is on antipsychotic that antagonizes D2)
Treatment for androgenic alopecia
Finasteride is a 5alpha-reductase inhibitor. Prevents conversion of testosterone to DHT
Treatent for hypertensive crisis
fenoldopam
selective dopamine 1 agonist
arteriolar dilation, increased renal perfusion, promotes diuresis and natruises